Endothelial	O
production	O
of	O
MCP-1	B-protein
:	O
modulation	O
by	O
heparin	O
and	O
consequences	O
for	O
mononuclear	O
cell	O
activation	O
.	O

Heparin	O
is	O
a	O
polyanionic	O
glycosaminoglycan	O
(	O
GAG	O
)	O
that	O
can	O
bind	O
with	O
high	O
affinity	O
to	O
a	O
range	O
of	O
cytokines	B-protein
including	O
interferon-gamma	B-protein
(	O
IFN-gamma	B-protein
)	O
and	O
members	O
of	O
the	O
chemokine	B-protein
superfamily	I-protein
.	O

This	O
GAG	O
also	O
possesses	O
immunomodulatory	O
activity	O
in	O
vivo	O
and	O
can	O
antagonize	O
the	O
capacity	O
of	O
IFN-gamma	B-protein
to	O
induce	O
class	B-protein
II	I-protein
MHC	I-protein
antigen	I-protein
expression	O
,	O
and	O
to	O
up-regulate	O
intercellular	B-protein
adhesion	I-protein
molecule-1	I-protein
,	O
by	O
cultured	B-cell_line
endothelial	I-cell_line
cells	I-cell_line
.	O

Previous	O
studies	O
have	O
shown	O
that	O
binding	O
to	O
cell-surface	O
heparan	O
sulphate	O
is	O
essential	O
for	O
optimal	O
activity	O
of	O
IFN-gamma	B-protein
and	O
that	O
free	O
heparin	O
competitively	O
inhibits	O
this	O
sequestration	O
process	O
.	O

The	O
present	O
study	O
was	O
performed	O
to	O
increase	O
our	O
understanding	O
of	O
the	O
immunosuppressive	O
activity	O
of	O
heparin	O
by	O
investigation	O
of	O
potential	O
antagonism	O
of	O
the	O
production	O
and	O
function	O
of	O
monocyte	B-protein
chemotactic	I-protein
peptide-1	I-protein
(	O
MCP-1	B-protein
)	O
,	O
a	O
chemokine	B-protein
important	O
for	O
mononuclear	O
leucocyte	O
recruitment	O
across	O
vascular	O
endothelium	O
.	O

It	O
was	O
found	O
that	O
mixture	O
of	O
heparin	O
with	O
IFN-gamma	B-protein
inhibited	O
up-regulation	O
of	O
the	O
signal	O
transducer	O
and	O
activator	O
of	O
transcription	O
protein	O
,	O
STAT-1	B-protein
produced	O
normally	O
by	O
treatment	O
of	O
endothelial	B-cell_type
cells	I-cell_type
with	O
IFN-gamma	B-protein
.	O

An	O
inhibition	O
of	O
MCP-1	B-protein
production	O
was	O
observed	O
that	O
was	O
specifically	O
caused	O
by	O
mixture	O
of	O
IFN-gamma	B-protein
with	O
heparin-like	O
,	O
and	O
therefore	O
cytokine-binding	O
,	O
GAGs	O
.	O

It	O
was	O
also	O
shown	O
that	O
mixture	O
of	O
heparin-like	O
GAGs	O
with	O
MCP-1	B-protein
inhibited	O
the	O
rapid	O
tyrosine	O
phosphorylation	O
of	O
phosphatidylinositol	B-protein
3-kinase	I-protein
which	O
is	O
normally	O
produced	O
by	O
treatment	O
of	O
mononuclear	B-cell_type
leucocytes	I-cell_type
with	O
this	O
chemokine	B-protein
.	O

Blockade	O
of	O
this	O
intracellular	O
signalling	O
event	O
was	O
associated	O
with	O
a	O
reduction	O
in	O
the	O
normal	O
transendothelial	O
migration	O
response	O
towards	O
MCP-1	B-protein
.	O

Results	O
from	O
this	O
study	O
indicate	O
that	O
soluble	O
,	O
heparin-like	O
GAGs	O
can	O
block	O
IFN-gamma	B-protein
-dependent	O
up-regulation	O
of	O
MCP-1	B-protein
production	O
by	O
cultured	B-cell_line
endothelial	I-cell_line
cells	I-cell_line
,	O
and	O
can	O
also	O
antagonize	O
the	O
leucocyte-activating	O
and	O
migration-promoting	O
properties	O
of	O
pre-existing	O
MCP-1	B-protein
.	O

These	O
activities	O
may	O
contribute	O
to	O
the	O
immunomodulatory	O
properties	O
of	O
heparin	O
.	O

Immunology	NULL
1997	NULL
92	NULL
512-518	NULL
Endothelial	NULL
production	NULL
of	NULL
MCP-1	NULL
:	NULL
modulation	NULL
by	NULL
heparin	NULL
and	NULL
consequences	NULL
for	NULL
mononuclear	NULL
cell	NULL
activation	NULL
M.	NULL
S.	NULL
DOUGLAS	NULL
,	NULL
S.	NULL
ALI	NULL
,	NULL
D.	NULL
A.	NULL
RIX	NULL
,	NULL
J.-G.	NULL
ZHANG	NULL
&	NULL
J	NULL
.	NULL

A.	NULL
KIRBY	NULL
Transplant	NULL
Immunobiology	NULL
Unit	NULL
,	NULL
Department	NULL
of	NULL
Surgery	NULL
,	NULL
University	NULL
of	NULL
Newcastle	NULL
,	NULL
Newcastle	NULL
upon	NULL
Tyne	NULL
,	NULL
UK	NULL
SUMMARY	NULL
Heparin	NULL
is	NULL
a	NULL
polyanionic	NULL
glycosaminoglycan	NULL
(	NULL
GAG	NULL
)	NULL
that	NULL
can	NULL
bind	NULL
with	NULL
high	NULL
affinity	NULL
to	NULL
a	NULL
range	NULL
of	NULL
cytokines	NULL
including	NULL
interferon-y	NULL
(	NULL
IFN-y	NULL
)	NULL
and	NULL
members	NULL
of	NULL
the	NULL
chemokine	NULL
superfamily	NULL
.	NULL

This	NULL
GAG	NULL
also	NULL
possesses	NULL
immunomodulatory	NULL
activity	NULL
in	NULL
vivo	NULL
and	NULL
can	NULL
antagonize	NULL
the	NULL
capacity	NULL
of	NULL
IFN-y	NULL
to	NULL
induce	NULL
class	NULL
II	NULL
MHC	NULL
antigen	NULL
expression	NULL
,	NULL
and	NULL
to	NULL
up-regulate	NULL
intercellular	NULL
adhesion	NULL
molecule-1	NULL
,	NULL
by	NULL
cultured	NULL
endothelial	NULL
cells	NULL
.	NULL

Previous	NULL
studies	NULL
have	NULL
shown	NULL
that	NULL
binding	NULL
to	NULL
cell-surface	NULL
heparan	NULL
sulphate	NULL
is	NULL
essential	NULL
for	NULL
optimal	NULL
activity	NULL
of	NULL
IFN-y	NULL
and	NULL
that	NULL
free	NULL
heparin	NULL
competitively	NULL
inhibits	NULL
this	NULL
sequestration	NULL
process	NULL
.	NULL

The	NULL
present	NULL
study	NULL
was	NULL
performed	NULL
to	NULL
increase	NULL
our	NULL
understanding	NULL
of	NULL
the	NULL
immunosuppressive	NULL
activity	NULL
of	NULL
heparin	NULL
by	NULL
investigation	NULL
of	NULL
potential	NULL
antagonism	NULL
of	NULL
the	NULL
production	NULL
and	NULL
function	NULL
of	NULL
monocyte	NULL
chemotactic	NULL
peptide-l	NULL
(	NULL
MCP-1	NULL
)	NULL
,	NULL
a	NULL
chemokine	NULL
important	NULL
for	NULL
mononuclear	NULL
leucocyte	NULL
recruitment	NULL
across	NULL
vascular	NULL
endothelium	NULL
.	NULL

It	NULL
was	NULL
found	NULL
that	NULL
mixture	NULL
of	NULL
heparin	NULL
with	NULL
IFN-y	NULL
inhibited	NULL
up-regulation	NULL
of	NULL
the	NULL
signal	NULL
transducer	NULL
and	NULL
activator	NULL
of	NULL
transcription	NULL
protein	NULL
,	NULL
STAT-1	NULL
produced	NULL
normally	NULL
by	NULL
treatment	NULL
of	NULL
endothelial	NULL
cells	NULL
with	NULL
IFN-y	NULL
.	NULL

An	NULL
inhibition	NULL
of	NULL
MCP-1	NULL
production	NULL
was	NULL
observed	NULL
that	NULL
was	NULL
specifically	NULL
caused	NULL
by	NULL
mixture	NULL
of	NULL
IFN-y	NULL
with	NULL
heparin-like	NULL
,	NULL
and	NULL
therefore	NULL
cytokine-binding	NULL
,	NULL
GAGs	NULL
.	NULL

It	NULL
was	NULL
also	NULL
shown	NULL
that	NULL
mixture	NULL
of	NULL
heparin-like	NULL
GAGs	NULL
with	NULL
MCP-1	NULL
inhibited	NULL
the	NULL
rapid	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
phosphatidylinositol	NULL
3-kinase	NULL
which	NULL
is	NULL
normally	NULL
produced	NULL
by	NULL
treatment	NULL
of	NULL
mononuclear	NULL
leucocytes	NULL
with	NULL
this	NULL
chemokine	NULL
.	NULL

Blockade	NULL
of	NULL
this	NULL
intracellular	NULL
signalling	NULL
event	NULL
was	NULL
associated	NULL
with	NULL
a	NULL
reduction	NULL
in	NULL
the	NULL
normal	NULL
transendothelial	NULL
migration	NULL
response	NULL
towards	NULL
MCP-1	NULL
.	NULL

Results	NULL
from	NULL
this	NULL
study	NULL
indicate	NULL
that	NULL
soluble	NULL
,	NULL
heparin-like	NULL
GAGs	NULL
can	NULL
block	NULL
IFN-y-dependent	NULL
up-regulation	NULL
of	NULL
MCP-1	NULL
production	NULL
by	NULL
cultured	NULL
endothelial	NULL
cells	NULL
,	NULL
and	NULL
can	NULL
also	NULL
antagonize	NULL
the	NULL
leucocyte-activating	NULL
and	NULL
migration-promoting	NULL
properties	NULL
of	NULL
pre-existing	NULL
MCP-1	NULL
.	NULL

These	NULL
activities	NULL
may	NULL
contribute	NULL
to	NULL
the	NULL
immunomodulatory	NULL
properties	NULL
of	NULL
heparin	NULL
.	NULL

INTRODUCTION	NULL
Interferon-y	NULL
(	NULL
IFN-y	NULL
)	NULL
is	NULL
an	NULL
important	NULL
proinflammatory	NULL
cytokine	NULL
,	NULL
playing	NULL
a	NULL
central	NULL
role	NULL
in	NULL
immune	NULL
and	NULL
inflammatory	NULL
responses	NULL
.	NULL

This	NULL
pleiotropic	NULL
molecule	NULL
is	NULL
produced	NULL
by	NULL
activated	NULL
CD8*	NULL
and	NULL
Thli-type	NULL
CD4*	NULL
T	NULL
cells	NULL
,	NULL
and	NULL
possesses	NULL
anti-viral	NULL
Received	NULL
3	NULL
August	NULL
1997	NULL
;	NULL
revised	NULL
5	NULL
September	NULL
1997	NULL
;	NULL
accepted	NULL
10	NULL
September	NULL
1997	NULL
.	NULL

Abbreviations	NULL
:	NULL
c.p.m	NULL
.	NULL

,	NULL
counts	NULL
per	NULL
minute	NULL
;	NULL
CS-C	NULL
,	NULL
chondroitin	NULL
sulphate-C	NULL
;	NULL
EBV	NULL
,	NULL
Epstein-Barr	NULL
virus	NULL
;	NULL
FBS	NULL
,	NULL
fetal	NULL
bovine	NULL
serum	NULL
;	NULL
GAG	NULL
,	NULL
glycosaminoglycan	NULL
;	NULL
HLE	NULL
,	NULL
human	NULL
lung	NULL
microvascular	NULL
endothelium	NULL
;	NULL
HS	NULL
,	NULL
heparan	NULL
sulphate	NULL
;	NULL
ICAM-1	NULL
,	NULL
intercellular	NULL
adhesion	NULL
molecule-1	NULL
;	NULL
IFN-y	NULL
,	NULL
interferon-y	NULL
;	NULL
JAK	NULL
,	NULL
Janus	NULL
kinase	NULL
;	NULL
MCP-1	NULL
,	NULL
monocyte	NULL
chemotactic	NULL
peptide-1	NULL
;	NULL
MLR	NULL
,	NULL
mixed	NULL
leucocyte	NULL
reaction	NULL
;	NULL
PBL	NULL
,	NULL
peripheral	NULL
blood	NULL
lymphocyte	NULL
;	NULL
PBMC	NULL
,	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
cell	NULL
;	NULL
PI	NULL
3-kinase	NULL
,	NULL
phosphatidylinositol	NULL
3-kinase	NULL
;	NULL
SEM	NULL
,	NULL
standard	NULL
error	NULL
of	NULL
the	NULL
mean	NULL
;	NULL
STAT	NULL
,	NULL
signal	NULL
transducer	NULL
and	NULL
activator	NULL
of	NULL
transcription	NULL
.	NULL

Correspondence	NULL
:	NULL
Dr	NULL
J	NULL
.	NULL

A.	NULL
Kirby	NULL
,	NULL
Transplant	NULL
Immunobiology	NULL
Unit	NULL
,	NULL
Department	NULL
of	NULL
Surgery	NULL
,	NULL
University	NULL
of	NULL
Newcastle	NULL
,	NULL
Newcastle-upon-Tyne	NULL
,	NULL
NE2	NULL
4HH	NULL
,	NULL
UK	NULL
.	NULL

and	NULL
phagocyte-activating	NULL
properties	NULL
.	NULL
``	NULL

A	NULL
further	NULL
effect	NULL
of	NULL
IFN-y	NULL
is	NULL
to	NULL
augment	NULL
the	NULL
potential	NULL
immunogenicity	NULL
of	NULL
a	NULL
variety	NULL
of	NULL
cells	NULL
,	NULL
such	NULL
as	NULL
those	NULL
of	NULL
vascular	NULL
endothelium	NULL
.	NULL
``	NULL

Specific	NULL
effects	NULL
on	NULL
endothelial	NULL
cells	NULL
include	NULL
up-regulation	NULL
of	NULL
the	NULL
expression	NULL
of	NULL
adhesion	NULL
molecules	NULL
,	NULL
such	NULL
as	NULL
intercellular	NULL
adhesion	NULL
molecule-1	NULL
(	NULL
ICAM-1	NULL
)	NULL
,	NULL
and	NULL
class	NULL
I1	NULL
major	NULL
histocompatibility	NULL
complex	NULL
(	NULL
MHC	NULL
)	NULL
antigens*	NULL
and	NULL
the	NULL
induction	NULL
of	NULL
class	NULL
I1	NULL
MHC	NULL
antigens	NULL
.	NULL

The	NULL
induction	NULL
of	NULL
endothelial	NULL
class	NULL
II	NULL
MHC	NULL
antigens	NULL
by	NULL
IFN-y	NULL
is	NULL
initiated	NULL
by	NULL
activation	NULL
of	NULL
the	NULL
Janus	NULL
kinase/signal	NULL
transducers	NULL
and	NULL
activators	NULL
of	NULL
transcription	NULL
(	NULL
JAK/STAT	NULL
)	NULL
intracellular	NULL
signalling	NULL
pathway*	NULL
which	NULL
,	NULL
in	NULL
turn	NULL
,	NULL
up-regulates	NULL
the	NULL
class	NULL
II	NULL
MHC	NULL
transactivator	NULL
.	NULL

The	NULL
surface	NULL
of	NULL
endothelium	NULL
is	NULL
covered	NULL
by	NULL
a	NULL
dense	NULL
layer	NULL
of	NULL
proteoglycans	NULL
,	NULL
the	NULL
main	NULL
functional	NULL
components	NULL
of	NULL
which	NULL
are	NULL
glycosaminoglycans	NULL
(	NULL
GAGs	NULL
)	NULL
.	NULL

The	NULL
most	NULL
abundant	NULL
endothelial	NULL
GAG	NULL
is	NULL
the	NULL
polyanionic	NULL
species	NULL
heparan	NULL
sulphate	NULL
(	NULL
HS	NULL
)	NULL
,	NULL
which	NULL
is	NULL
structurally	NULL
and	NULL
biosynthetically	NULL
related	NULL
to	NULL
heparin	NULL
.	NULL

>	NULL
Heparin	NULL
is	NULL
known	NULL
to	NULL
bind	NULL
with	NULL
high	NULL
affinity	NULL
a	NULL
range	NULL
of	NULL
growth	NULL
factors	NULL
and	NULL
cytokines	NULL
,	NULL
including	NULL
the	NULL
chemokines	NULL
,	NULL
®	NULL
interleukin-1	NULL
(	NULL
IL-1	NULL
)	NULL
,	NULL
IL-2	NULL
,	NULL
IL-3	NULL
,	NULL
IL-6	NULL
,	NULL
``	NULL
tumour	NULL
necrosis	NULL
factor	NULL
``	NULL
and	NULL
IFN-y	NULL
.	NULL
``	NULL

There	NULL
©1997	NULL
Blackwell	NULL
Science	NULL
Ltd	NULL
Modulation	NULL
of	NULL
cytokines	NULL
by	NULL
heparin	NULL
513	NULL
is	NULL
growing	NULL
evidence	NULL
that	NULL
an	NULL
important	NULL
function	NULL
of	NULL
endothelial	NULL
cell	NULL
surface	NULL
HS	NULL
is	NULL
to	NULL
bind	NULL
cytokines	NULL
,	NULL
so	NULL
that	NULL
their	NULL
effective	NULL
local	NULL
concentration	NULL
is	NULL
maintained	NULL
.	NULL

In	NULL
the	NULL
absence	NULL
of	NULL
such	NULL
a	NULL
mechanism	NULL
,	NULL
cytokines	NULL
would	NULL
lose	NULL
biological	NULL
activity	NULL
rapidly	NULL
by	NULL
dilution	NULL
into	NULL
the	NULL
blood	NULL
or	NULL
tissue	NULL
fluids	NULL
;	NULL
this	NULL
is	NULL
an	NULL
essential	NULL
function	NULL
on	NULL
the	NULL
luminal	NULL
surface	NULL
of	NULL
endothelium	NULL
where	NULL
blood	NULL
flow	NULL
is	NULL
rapid	NULL
.	NULL

Previous	NULL
studies	NULL
by	NULL
this	NULL
group	NULL
'	NULL
``	NULL
and	NULL
others	NULL
'	NULL
have	NULL
shown	NULL
that	NULL
soluble	NULL
,	NULL
heparin-like	NULL
GAGs	NULL
are	NULL
able	NULL
to	NULL
antagonize	NULL
the	NULL
biological	NULL
activity	NULL
of	NULL
IFN-y	NULL
in	NULL
vitro	NULL
.	NULL

It	NULL
is	NULL
proposed	NULL
that	NULL
this	NULL
effect	NULL
is	NULL
produced	NULL
by	NULL
competition	NULL
between	NULL
free	NULL
heparin	NULL
and	NULL
cell-surface	NULL
HS	NULL
to	NULL
bind	NULL
this	NULL
cytokine	NULL
resulting	NULL
in	NULL
reduced	NULL
bioavailability	NULL
,	NULL
and	NULL
hence	NULL
activity	NULL
,	NULL
at	NULL
the	NULL
cell	NULL
surface	NULL
.	NULL

This	NULL
finding	NULL
may	NULL
go	NULL
some	NULL
way	NULL
to	NULL
explaining	NULL
reports	NULL
that	NULL
heparin	NULL
has	NULL
immunosuppressive	NULL
properties	NULL
.	NULL

For	NULL
example	NULL
,	NULL
it	NULL
is	NULL
known	NULL
that	NULL
heparin	NULL
can	NULL
reduce	NULL
the	NULL
severity	NULL
of	NULL
the	NULL
inflammatory	NULL
autoimmune	NULL
disease	NULL
experimental	NULL
allergic	NULL
encephalomyelitis'*	NULL
and	NULL
can	NULL
delay	NULL
skin'*	NULL
and	NULL
solid	NULL
organ	NULL
allograft	NULL
rejection	NULL
.	NULL
``	NULL

Previous	NULL
studies	NULL
have	NULL
shown	NULL
that	NULL
anti-IFN-y	NULL
antibodies	NULL
can	NULL
also	NULL
delay	NULL
renal	NULL
allograft	NULL
rejection	NULL
,	NULL
'	NULL
``	NULL
whilst	NULL
IFN-y	NULL
knockout	NULL
mice	NULL
show	NULL
an	NULL
atypical	NULL
allograft	NULL
rejection	NULL
response	NULL
.	NULL
``	NULL

''	NULL
Recent	NULL
studies	NULL
have	NULL
identified	NULL
members	NULL
of	NULL
a	NULL
superfamily	NULL
of	NULL
low	NULL
molecular	NULL
weight	NULL
proteins	NULL
,	NULL
termed	NULL
the	NULL
chemokines	NULL
,	NULL
as	NULL
critical	NULL
regulators	NULL
of	NULL
leucocyte	NULL
infiltration	NULL
of	NULL
sub-endothelial	NULL
tissues	NULL
at	NULL
sites	NULL
of	NULL
inflammation	NULL
.	NULL

In	NULL
this	NULL
respect	NULL
it	NULL
is	NULL
significant	NULL
that	NULL
endothelial	NULL
cells	NULL
can	NULL
be	NULL
induced	NULL
to	NULL
produce	NULL
chemokines	NULL
,	NULL
``	NULL
``	NULL
and	NULL
that	NULL
these	NULL
molecules	NULL
bind	NULL
with	NULL
high	NULL
affinity	NULL
to	NULL
HS	NULL
and	NULL
heparin.©	NULL
Production	NULL
of	NULL
the	NULL
chemokine	NULL
monocyte	NULL
chemotactic	NULL
peptide-1	NULL
(	NULL
MCP-1	NULL
)	NULL
can	NULL
be	NULL
induced	NULL
by	NULL
treatment	NULL
of	NULL
endothelial	NULL
cells	NULL
with	NULL
IFN-y	NULL
;	NULL
*°	NULL
this	NULL
chemokine	NULL
is	NULL
generally	NULL
considered	NULL
to	NULL
be	NULL
important	NULL
for	NULL
inducing	NULL
intravascular	NULL
adhesion	NULL
and	NULL
transendothelial	NULL
chemotaxis	NULL
of	NULL
monocytes	NULL
and	NULL
T	NULL
lymphocytes	NULL
.	NULL
``	NULL

It	NULL
has	NULL
been	NULL
shown	NULL
recently	NULL
that	NULL
activation	NULL
of	NULL
phosphatidylinositol	NULL
3-kinase	NULL
(	NULL
PI	NULL
3-kinase	NULL
)	NULL
plays	NULL
an	NULL
important	NULL
role	NULL
in	NULL
chemokine	NULL
signal	NULL
transduction	NULL
leading	NULL
to	NULL
leucocyte	NULL
chemotaxis	NULL
.	NULL
``	NULL

''	NULL
The	NULL
present	NULL
study	NULL
was	NULL
designed	NULL
to	NULL
examine	NULL
further	NULL
aspects	NULL
of	NULL
the	NULL
anti-inflammatory	NULL
effect	NULL
of	NULL
heparin	NULL
.	NULL

Microvascular	NULL
endothelial	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
IFN-y	NULL
and	NULL
the	NULL
effects	NULL
of	NULL
heparin	NULL
addition	NULL
on	NULL
cytoplasmic	NULL
signal	NULL
transduction	NULL
events	NULL
and	NULL
on	NULL
the	NULL
production	NULL
of	NULL
MCP-1	NULL
were	NULL
assessed	NULL
by	NULL
Western	NULL
blotting	NULL
and	NULL
enzyme-linked	NULL
immunosorbent	NULL
assay	NULL
(	NULL
ELISA	NULL
)	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
consequences	NULL
for	NULL
allograft	NULL
rejection	NULL
of	NULL
reduced	NULL
MCP-1	NULL
production	NULL
were	NULL
modelled	NULL
by	NULL
examination	NULL
of	NULL
T-cell	NULL
activation	NULL
and	NULL
chemotactic	NULL
responses	NULL
to	NULL
recombinant	NULL
MCP-1	NULL
and	NULL
to	NULL
the	NULL
chemokines	NULL
produced	NULL
by	NULL
microvascular	NULL
endothelial	NULL
cells	NULL
treated	NULL
with	NULL
supernatant	NULL
from	NULL
an	NULL
allogeneic	NULL
mixed	NULL
leucocyte	NULL
reaction	NULL
(	NULL
MLR	NULL
)	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Culture	NULL
of	NULL
human	NULL
lung	NULL
microvascular	NULL
endothelial	NULL
cells	NULL
Human	NULL
lung	NULL
microvascular	NULL
endothelial	NULL
(	NULL
HLE	NULL
)	NULL
cells	NULL
from	NULL
single	NULL
donors	NULL
were	NULL
obtained	NULL
at	NULL
passage	NULL
4	NULL
(	NULL
Clonetics	NULL
;	NULL
TCS	NULL
Biologicals	NULL
,	NULL
Buckingham	NULL
,	NULL
UK	NULL
)	NULL
and	NULL
cultured	NULL
in	NULL
endothelial	NULL
cell	NULL
growth	NULL
medium	NULL
(	NULL
BulletKit	NULL
;	NULL
Clonetics	NULL
)	NULL
supplemented	NULL
with	NULL
heparin-free	NULL
bovine	NULL
brain	NULL
extract	NULL
(	NULL
Clonetics	NULL
)	NULL
.	NULL

Prior	NULL
to	NULL
dispatch	NULL
all	NULL
cultures	NULL
were	NULL
tested	NULL
for	NULL
expression	NULL
of	NULL
factor	NULL
VIII-related	NULL
antigen	NULL
and	NULL
CD31	NULL
,	NULL
and	NULL
for	NULL
the	NULL
uptake	NULL
of	NULL
low-density	NULL
lipoproteins	NULL
.	NULL

The	NULL
HLE	NULL
cells	NULL
were	NULL
grown	NULL
in	NULL
25	NULL
cm	NULL
flasks	NULL
(	NULL
Corning	NULL
,	NULL
Stone	NULL
,	NULL
UK	NULL
)	NULL
at	NULL
37°	NULL
in	NULL
an	NULL
atmosphere	NULL
containing	NULL
5	NULL
%	NULL
CO	NULL
;	NULL
in	NULL
air	NULL
,	NULL
and	NULL
were	NULL
©1997	NULL
Blackwell	NULL
Science	NULL
Ltd	NULL
,	NULL
Immunology	NULL
,	NULL
92	NULL
,	NULL
512-518	NULL
subcultured	NULL
every	NULL
4-5	NULL
days	NULL
.	NULL

Experiments	NULL
were	NULL
performed	NULL
using	NULL
cultures	NULL
between	NULL
passages	NULL
8	NULL
and	NULL
11	NULL
.	NULL

Preparation	NULL
of	NULL
leucocyte	NULL
populations	NULL
Peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
(	NULL
PBMC	NULL
)	NULL
were	NULL
isolated	NULL
from	NULL
heparinized	NULL
blood	NULL
samples	NULL
,	NULL
taken	NULL
from	NULL
healthy	NULL
volun-teers	NULL
.	NULL

Blood	NULL
samples	NULL
were	NULL
diluted	NULL
1	NULL
:	NULL
1	NULL
with	NULL
RPMI-1640	NULL
culture	NULL
medium	NULL
(	NULL
Gibco	NULL
BRL	NULL
,	NULL
Paisley	NULL
,	NULL
UK	NULL
)	NULL
and	NULL
underlayed	NULL
with	NULL
Ficoll-Hypaque	NULL
at	NULL
1-077	NULL
g/ml	NULL
(	NULL
Lymphoprep	NULL
;	NULL
Nycomed	NULL
,	NULL
Birmingham	NULL
,	NULL
UK	NULL
)	NULL
.	NULL

Following	NULL
centrifugation	NULL
at	NULL
400g	NULL
for	NULL
25	NULL
min	NULL
,	NULL
the	NULL
interfacial	NULL
cells	NULL
were	NULL
collected	NULL
,	NULL
washed	NULL
twice	NULL
and	NULL
resuspended	NULL
at	NULL
the	NULL
appropriate	NULL
concentration	NULL
in	NULL
complete	NULL
culture	NULL
medium	NULL
consisting	NULL
of	NULL
RPMI-1640	NULL
medium	NULL
containing	NULL
10	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
(	NULL
FBS	NULL
;	NULL
Gibco	NULL
BRL	NULL
)	NULL
,	NULL
100	NULL
U/ml	NULL
!	NULL

penicillin	NULL
and	NULL
100	NULL
ug/ml	NULL
streptomycin	NULL
(	NULL
Sigma	NULL
,	NULL
Poole	NULL
,	NULL
UK	NULL
)	NULL
.	NULL

Peripheral	NULL
blood	NULL
lymphocytes	NULL
(	NULL
PBL	NULL
)	NULL
were	NULL
prepared	NULL
by	NULL
depletion	NULL
of	NULL
monocytes	NULL
from	NULL
PBMC	NULL
populations	NULL
.	NULL

Cells	NULL
were	NULL
incubated	NULL
at	NULL
37°	NULL
for	NULL
45	NULL
min	NULL
in	NULL
a	NULL
culture	NULL
flask	NULL
containing	NULL
10	NULL
ml	NULL
of	NULL
complete	NULL
RPMI	NULL
culture	NULL
medium	NULL
,	NULL
after	NULL
which	NULL
time	NULL
non-adherent	NULL
cells	NULL
were	NULL
recovered	NULL
and	NULL
resuspended	NULL
at	NULL
the	NULL
required	NULL
concentration	NULL
.	NULL

Generation	NULL
of	NULL
an	NULL
Epstein-Barr	NULL
virus-transformed	NULL
B-cell	NULL
line	NULL
An	NULL
immortalized	NULL
B-cell	NULL
line	NULL
was	NULL
obtained	NULL
by	NULL
transformation	NULL
of	NULL
a	NULL
lymphocyte	NULL
preparation	NULL
,	NULL
using	NULL
methodology	NULL
previously	NULL
described	NULL
.	NULL
``	NULL

Briefly	NULL
,	NULL
1x	NULL
10	NULL
'	NULL
PBL	NULL
were	NULL
treated	NULL
with	NULL
culture	NULL
supernatant	NULL
from	NULL
the	NULL
Epstein-Barr	NULL
virus	NULL
(	NULL
EBV	NULL
)	NULL
-secreting	NULL
B95-8	NULL
cell	NULL
line	NULL
(	NULL
ECACC	NULL
8501419	NULL
;	NULL
Porton	NULL
Down	NULL
,	NULL
UK	NULL
)	NULL
.	NULL

Cyclosporin	NULL
A	NULL
(	NULL
1	NULL
ug/ml	NULL
;	NULL
Sandoz	NULL
,	NULL
Basle	NULL
,	NULL
Switzerland	NULL
)	NULL
was	NULL
added	NULL
to	NULL
the	NULL
initial	NULL
cell	NULL
culture	NULL
,	NULL
to	NULL
prevent	NULL
activation	NULL
of	NULL
specific	NULL
T	NULL
cells	NULL
.	NULL

The	NULL
outgrowing	NULL
B	NULL
cells	NULL
were	NULL
maintained	NULL
in	NULL
complete	NULL
RPMI	NULL
culture	NULL
medium	NULL
,	NULL
in	NULL
upright	NULL
75	NULL
cm	NULL
flasks	NULL
(	NULL
Corning	NULL
)	NULL
and	NULL
were	NULL
subcultured	NULL
in	NULL
the	NULL
ratio	NULL
1:3	NULL
,	NULL
at	NULL
4-5-day	NULL
intervals	NULL
.	NULL

Mixed	NULL
leucocyte	NULL
reaction	NULL
A	NULL
two-way	NULL
MLR	NULL
was	NULL
set	NULL
up	NULL
in	NULL
a	NULL
canted	NULL
75	NULL
cm	NULL
flask	NULL
containing	NULL
1	NULL
x	NULL
10	NULL
``	NULL
PBMC	NULL
and	NULL
1	NULL
x	NULL
10	NULL
``	NULL
EBV-transformed	NULL
B	NULL
cells	NULL
in	NULL
a	NULL
total	NULL
volume	NULL
of	NULL
20	NULL
ml	NULL
.	NULL

Culture	NULL
supernatant	NULL
was	NULL
collected	NULL
after	NULL
72	NULL
hr	NULL
,	NULL
centrifuged	NULL
to	NULL
remove	NULL
cellular	NULL
debris	NULL
,	NULL
and	NULL
subsequently	NULL
used	NULL
to	NULL
stimulate	NULL
endothelial	NULL
cells	NULL
.	NULL

Cytokine	NULL
stimulation	NULL
of	NULL
endothelial	NULL
cells	NULL
For	NULL
experimental	NULL
use	NULL
,	NULL
endothelial	NULL
cells	NULL
were	NULL
grown	NULL
in	NULL
24-well	NULL
cluster	NULL
plates	NULL
(	NULL
Corning	NULL
)	NULL
.	NULL

Once	NULL
confluent	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
washed	NULL
and	NULL
500	NULL
ul	NULL
of	NULL
RPMI-1640	NULL
medium	NULL
supplemented	NULL
with	NULL
5	NULL
%	NULL
FBS	NULL
(	NULL
RPMI/5	NULL
%	NULL
FBS	NULL
)	NULL
and	NULL
100	NULL
U/ml	NULL
of	NULL
recombinant	NULL
IFN-y	NULL
(	NULL
R	NULL
&	NULL
D	NULL
Systems	NULL
,	NULL
Abingdon	NULL
,	NULL
UK	NULL
)	NULL
was	NULL
added	NULL
.	NULL

In	NULL
some	NULL
wells	NULL
,	NULL
GAGs	NULL
were	NULL
also	NULL
added	NULL
to	NULL
the	NULL
medium	NULL
;	NULL
these	NULL
included	NULL
heparin	NULL
(	NULL
Sigma	NULL
)	NULL
,	NULL
HS	NULL
(	NULL
Leo	NULL
Pharmaceutical	NULL
Products	NULL
,	NULL
Copenhagen	NULL
,	NULL
Denmark	NULL
)	NULL
and	NULL
chondroitin	NULL
sulphateeC	NULL
(	NULL
CS-C	NULL
;	NULL
Sigma	NULL
)	NULL
,	NULL
at	NULL
concentrations	NULL
between	NULL
0	NULL
and	NULL
250	NULL
ug/ml	NULL
.	NULL

Following	NULL
cytokine	NULL
treatment	NULL
for	NULL
24	NULL
hr	NULL
,	NULL
culture	NULL
supernatants	NULL
were	NULL
collected	NULL
and	NULL
the	NULL
MCP-1	NULL
concentration	NULL
in	NULL
each	NULL
was	NULL
measured	NULL
by	NULL
quantitative	NULL
sandwich	NULL
enzyme	NULL
immunoassay	NULL
(	NULL
R	NULL
&	NULL
D	NULL
Systems	NULL
)	NULL
.	NULL

Control	NULL
experiments	NULL
demonstrated	NULL
that	NULL
this	NULL
assay	NULL
was	NULL
not	NULL
influenced	NULL
by	NULL
the	NULL
presence	NULL
of	NULL
heparin	NULL
,	NULL
implying	NULL
that	NULL
the	NULL
antibodies	NULL
recognize	NULL
epitopes	NULL
that	NULL
are	NULL
remote	NULL
from	NULL
GAG-binding	NULL
domains	NULL
.	NULL

Further	NULL
experiments	NULL
were	NULL
performed	NULL
,	NULL
in	NULL
which	NULL
endothelial	NULL
cells	NULL
were	NULL
stimulated	NULL
using	NULL
culture	NULL
supernatant	NULL
from	NULL
a	NULL
MLR	NULL
.	NULL

Confluent	NULL
cells	NULL
in	NULL
a	NULL
25	NULL
cm	NULL
``	NULL
flask	NULL
were	NULL
treated	NULL
with	NULL
3	NULL
ml	NULL
of	NULL
514	NULL
M.	NULL
S.	NULL
Douglas	NULL
et	NULL
al	NULL
.	NULL

MLR	NULL
supernatant	NULL
for	NULL
24	NULL
hr	NULL
,	NULL
after	NULL
which	NULL
time	NULL
they	NULL
were	NULL
washed	NULL
three	NULL
times	NULL
with	NULL
culture	NULL
medium	NULL
and	NULL
incubated	NULL
for	NULL
a	NULL
further	NULL
24	NULL
hr	NULL
in	NULL
3	NULL
ml	NULL
of	NULL
RPMI/5	NULL
%	NULL
FBS	NULL
.	NULL

Finally	NULL
,	NULL
the	NULL
culture	NULL
supernatants	NULL
were	NULL
collected	NULL
and	NULL
either	NULL
analysed	NULL
for	NULL
MCP-1	NULL
content	NULL
by	NULL
ELISA	NULL
,	NULL
or	NULL
used	NULL
to	NULL
stimulate	NULL
PBMC	NULL
in	NULL
subsequent	NULL
assays	NULL
.	NULL

In	NULL
order	NULL
to	NULL
investigate	NULL
the	NULL
effect	NULL
of	NULL
IFN-y	NULL
on	NULL
expression	NULL
of	NULL
signal	NULL
transducer	NULL
and	NULL
activator	NULL
of	NULL
transcription-1	NULL
protein	NULL
(	NULL
STAT-1	NULL
)	NULL
in	NULL
endothelium	NULL
,	NULL
HLE	NULL
cells	NULL
were	NULL
grown	NULL
to	NULL
confluence	NULL
in	NULL
75	NULL
cm*	NULL
flasks	NULL
.	NULL

These	NULL
cells	NULL
were	NULL
then	NULL
treated	NULL
for	NULL
18	NULL
hr	NULL
with	NULL
IFN-y	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
250	NULL
ug/ml	NULL
heparin	NULL
,	NULL
after	NULL
which	NULL
time	NULL
they	NULL
were	NULL
detached	NULL
from	NULL
the	NULL
surface	NULL
using	NULL
sterile	NULL
scrapers	NULL
(	NULL
Corning	NULL
)	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
recovered	NULL
by	NULL
centrifugation	NULL
,	NULL
washed	NULL
once	NULL
in	NULL
phosphate-buffered	NULL
saline	NULL
(	NULL
PBS	NULL
)	NULL
,	NULL
and	NULL
lysed	NULL
by	NULL
addition	NULL
of	NULL
250	NULL
ul	NULL
of	NULL
gel-loading	NULL
buffer	NULL
consisting	NULL
of	NULL
125	NULL
mm	NULL
Tris-HCl	NULL
(	NULL
pH	NULL
6:8	NULL
)	NULL
,	NULL
2	NULL
%	NULL
sodium	NULL
dodecyl	NULL
sulphate	NULL
(	NULL
SDS	NULL
)	NULL
,	NULL
10	NULL
%	NULL
glycerol	NULL
,	NULL
10	NULL
%	NULL
2-mercaptoethanol	NULL
and	NULL
0:001	NULL
%	NULL
bromophenol	NULL
blue	NULL
.	NULL

Cell	NULL
lysates	NULL
were	NULL
then	NULL
analysed	NULL
by	NULL
Western	NULL
blotting	NULL
.	NULL

Transendothelial	NULL
migration	NULL
assays	NULL
HLE	NULL
cells	NULL
were	NULL
grown	NULL
to	NULL
confluence	NULL
on	NULL
cell	NULL
culture	NULL
membrane	NULL
inserts	NULL
of	NULL
3-um	NULL
pore	NULL
size	NULL
(	NULL
Falcon	NULL
;	NULL
Becton	NULL
Dickinson	NULL
,	NULL
Cowley	NULL
,	NULL
UK	NULL
)	NULL
.	NULL

Inserts	NULL
were	NULL
placed	NULL
in	NULL
the	NULL
wells	NULL
of	NULL
a	NULL
24-well	NULL
companion	NULL
plate	NULL
(	NULL
Falcon	NULL
)	NULL
containing	NULL
l1ml	NULL
of	NULL
RPMI/5	NULL
%	NULL
FBS	NULL
and	NULL
0-10	NULL
ng/ml	NULL
of	NULL
MCP-1	NULL
.	NULL

For	NULL
some	NULL
experiments	NULL
10	NULL
ng/ml	NULL
of	NULL
MCP-1	NULL
was	NULL
pre-mixed	NULL
with	NULL
100	NULL
ug/ml	NULL
of	NULL
heparin	NULL
or	NULL
CS-C	NULL
prior	NULL
to	NULL
addition	NULL
to	NULL
the	NULL
culture	NULL
wells	NULL
Mononuclear	NULL
cells	NULL
(	NULL
1x	NULL
10°	NULL
cells	NULL
)	NULL
were	NULL
then	NULL
added	NULL
to	NULL
the	NULL
upper	NULL
surface	NULL
of	NULL
the	NULL
membrane	NULL
inserts	NULL
,	NULL
and	NULL
the	NULL
plate	NULL
was	NULL
incubated	NULL
for	NULL
3	NULL
hr	NULL
at	NULL
37°	NULL
.	NULL

The	NULL
number	NULL
of	NULL
cells	NULL
in	NULL
each	NULL
well	NULL
migrating	NULL
across	NULL
the	NULL
endothelial	NULL
monolayer	NULL
was	NULL
quantified	NULL
using	NULL
a	NULL
rapid	NULL
flow	NULL
cytometric	NULL
method	NULL
.	NULL

Cells	NULL
were	NULL
recovered	NULL
from	NULL
each	NULL
well	NULL
,	NULL
washed	NULL
by	NULL
centrifugation	NULL
and	NULL
resuspended	NULL
in	NULL
200	NULL
ul	NULL
of	NULL
PBS	NULL
.	NULL

Five	NULL
micro-litres	NULL
of	NULL
a	NULL
uniformly	NULL
mixed	NULL
suspension	NULL
of	NULL
fluorescent	NULL
spheres	NULL
(	NULL
Immuno-Check	NULL
;	NULL
Coulter	NULL
Electronics	NULL
,	NULL
Luton	NULL
,	NULL
UK	NULL
)	NULL
was	NULL
then	NULL
added	NULL
to	NULL
each	NULL
sample	NULL
.	NULL

The	NULL
resulting	NULL
mixture	NULL
of	NULL
cells	NULL
and	NULL
fluorescent	NULL
spheres	NULL
was	NULL
analysed	NULL
by	NULL
flow	NULL
cytometry	NULL
(	NULL
FACScan	NULL
;	NULL
Becton	NULL
Dickinson	NULL
)	NULL
and	NULL
Lysis	NULL
II	NULL
software	NULL
(	NULL
Becton	NULL
Dickinson	NULL
)	NULL
was	NULL
used	NULL
to	NULL
separate	NULL
the	NULL
two	NULL
particle	NULL
populations	NULL
.	NULL

The	NULL
ratio	NULL
of	NULL
cells	NULL
to	NULL
fluorescent	NULL
beads	NULL
was	NULL
used	NULL
to	NULL
provide	NULL
a	NULL
rapid	NULL
measure	NULL
of	NULL
the	NULL
number	NULL
of	NULL
migrant	NULL
mononuclear	NULL
leucocytes	NULL
in	NULL
each	NULL
sample	NULL
;	NULL
all	NULL
results	NULL
were	NULL
normalized	NULL
to	NULL
control	NULL
levels	NULL
of	NULL
migration	NULL
.	NULL

A	NULL
further	NULL
series	NULL
of	NULL
experiments	NULL
was	NULL
performed	NULL
to	NULL
determine	NULL
the	NULL
capacity	NULL
of	NULL
culture	NULL
supernatants	NULL
,	NULL
collected	NULL
previously	NULL
from	NULL
endothelial	NULL
cells	NULL
treated	NULL
with	NULL
normal	NULL
or	NULL
MLR-conditioned	NULL
medium	NULL
,	NULL
to	NULL
induce	NULL
transendothelial	NULL
migration	NULL
of	NULL
PBMC	NULL
.	NULL

The	NULL
effect	NULL
on	NULL
chemotaxis	NULL
of	NULL
the	NULL
addition	NULL
of	NULL
heparin	NULL
or	NULL
CS-C	NULL
at	NULL
250	NULL
ug/ml	NULL
to	NULL
the	NULL
endothelial	NULL
culture	NULL
supernatants	NULL
was	NULL
also	NULL
evaluated	NULL
.	NULL

Cytokine	NULL
stimulation	NULL
of	NULL
PBMC	NULL
PBMC	NULL
(	NULL
2:5	NULL
x	NULL
10°	NULL
cells/ml	NULL
)	NULL
were	NULL
treated	NULL
for	NULL
between	NULL
0	NULL
and	NULL
30	NULL
min	NULL
at	NULL
37°	NULL
with	NULL
pre-warmed	NULL
complete	NULL
culture	NULL
medium	NULL
containing	NULL
15	NULL
ng/ml	NULL
of	NULL
recombinant	NULL
MCP-1	NULL
(	NULL
R	NULL
&	NULL
D	NULL
Systems	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
pelleted	NULL
by	NULL
centrifugation	NULL
at	NULL
4°	NULL
and	NULL
lysed	NULL
by	NULL
addition	NULL
of	NULL
100	NULL
pul	NULL
of	NULL
gel-loading	NULL
buffer	NULL
,	NULL
prior	NULL
to	NULL
analysis	NULL
by	NULL
Western	NULL
blotting	NULL
.	NULL

For	NULL
some	NULL
experiments	NULL
the	NULL
MCP-1	NULL
was	NULL
pre-mixed	NULL
with	NULL
100	NULL
ug/ml	NULL
!	NULL

of	NULL
heparin	NULL
or	NULL
CS-C	NULL
prior	NULL
to	NULL
addition	NULL
to	NULL
the	NULL
leucocytes	NULL
for	NULL
10	NULL
min	NULL
.	NULL

In	NULL
further	NULL
experiments	NULL
,	NULL
PBMC	NULL
were	NULL
stimulated	NULL
with	NULL
1:5	NULL
ml	NULL
of	NULL
culture	NULL
supernatants	NULL
collected	NULL
previously	NULL
from	NULL
endothelial	NULL
cells	NULL
treated	NULL
with	NULL
normal	NULL
culture	NULL
medium	NULL
or	NULL
MLR	NULL
supernatant	NULL
.	NULL

Stimulation	NULL
was	NULL
performed	NULL
for	NULL
up	NULL
to	NULL
15	NULL
min	NULL
at	NULL
37°	NULL
,	NULL
after	NULL
which	NULL
time	NULL
the	NULL
cells	NULL
were	NULL
lysed	NULL
and	NULL
their	NULL
protein	NULL
content	NULL
was	NULL
analysed	NULL
by	NULL
Western	NULL
blotting	NULL
.	NULL

Western	NULL
analysis	NULL
Electrophoresis	NULL
of	NULL
protein	NULL
samples	NULL
was	NULL
carried	NULL
out	NULL
using	NULL
10	NULL
%	NULL
SDS-polyacrylamide	NULL
gels	NULL
,	NULL
and	NULL
proteins	NULL
were	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
filters	NULL
(	NULL
Hybond-C	NULL
;	NULL
Amersham	NULL
International	NULL
,	NULL
Little	NULL
Chalfont	NULL
,	NULL
UK	NULL
)	NULL
by	NULL
electroblotting	NULL
.	NULL

Filters	NULL
were	NULL
blocked	NULL
using	NULL
protocols	NULL
specified	NULL
by	NULL
the	NULL
suppliers	NULL
of	NULL
the	NULL
antibody	NULL
to	NULL
be	NULL
used	NULL
for	NULL
subsequent	NULL
immunodetection	NULL
.	NULL

After	NULL
blocking	NULL
,	NULL
filters	NULL
were	NULL
incubated	NULL
with	NULL
antibodies	NULL
directed	NULL
against	NULL
STAT-1	NULL
(	NULL
1	NULL
:	NULL
2500	NULL
dilution	NULL
;	NULL
Transduction	NULL
Laboratories	NULL
;	NULL
Affiniti	NULL
Research	NULL
Products	NULL
,	NULL
Exeter	NULL
,	NULL
UK	NULL
)	NULL
,	NULL
PI	NULL
3-kinase	NULL
(	NULL
85000	NULL
MW	NULL
subunit	NULL
,	NULL
1	NULL
:	NULL
5000	NULL
dilution	NULL
;	NULL
Transduction	NULL
Laboratories	NULL
)	NULL
,	NULL
or	NULL
phosphotyrosine	NULL
residues	NULL
(	NULL
1:2500	NULL
dilution	NULL
;	NULL
Transduction	NULL
Laboratories	NULL
)	NULL
.	NULL

Filters	NULL
were	NULL
then	NULL
washed	NULL
,	NULL
and	NULL
protein	NULL
was	NULL
visualized	NULL
using	NULL
a	NULL
chemiluminescence	NULL
system	NULL
(	NULL
ECL	NULL
;	NULL
Amersham	NULL
International	NULL
)	NULL
with	NULL
polyclonal	NULL
horseradish	NULL
peroxidase-conjugated	NULL
secondary	NULL
antibodies	NULL
(	NULL
Transduction	NULL
Laboratories	NULL
)	NULL
.	NULL

The	NULL
phosphotyrosine	NULL
content	NULL
of	NULL
PI	NULL
3-kinase	NULL
was	NULL
assessed	NULL
by	NULL
sequential	NULL
identification	NULL
,	NULL
and	NULL
quantification	NULL
of	NULL
both	NULL
antigens	NULL
on	NULL
the	NULL
same	NULL
filter	NULL
.	NULL

In	NULL
order	NULL
to	NULL
reprobe	NULL
the	NULL
filters	NULL
,	NULL
they	NULL
were	NULL
stripped	NULL
of	NULL
antibodies	NULL
by	NULL
incubation	NULL
at	NULL
50°	NULL
for	NULL
45	NULL
min	NULL
in	NULL
62:5	NULL
mm	NULL
Tris-HCI	NULL
(	NULL
pH	NULL
7-6	NULL
)	NULL
containing	NULL
100	NULL
mm	NULL
2-mercaptoethanol	NULL
,	NULL
and	NULL
washed	NULL
three	NULL
times	NULL
.	NULL

Following	NULL
development	NULL
,	NULL
the	NULL
relative	NULL
intensity	NULL
of	NULL
the	NULL
bands	NULL
was	NULL
measured	NULL
by	NULL
densitometric	NULL
analysis	NULL
using	NULL
Molecular	NULL
Analyst	NULL
computer	NULL
software	NULL
(	NULL
BioRad	NULL
,	NULL
Hemel	NULL
Hempstead	NULL
,	NULL
UK	NULL
)	NULL
.	NULL

The	NULL
relative	NULL
protein	NULL
loading	NULL
of	NULL
each	NULL
lane	NULL
was	NULL
assessed	NULL
by	NULL
densitometry	NULL
of	NULL
duplicate	NULL
gels	NULL
following	NULL
standard	NULL
Coomassie	NULL
blue	NULL
staining	NULL
.	NULL

Statistical	NULL
analysis	NULL
Results	NULL
were	NULL
routinely	NULL
calculated	NULL
as	NULL
the	NULL
mean	NULL
+	NULL
the	NULL
standard	NULL
error	NULL
of	NULL
the	NULL
mean	NULL
(	NULL
SEM	NULL
)	NULL
.	NULL

The	NULL
significance	NULL
of	NULL
experimental	NULL
changes	NULL
was	NULL
assessed	NULL
by	NULL
application	NULL
of	NULL
Student	NULL
's	NULL
r-test	NULL
.	NULL

All	NULL
data	NULL
analysis	NULL
was	NULL
performed	NULL
using	NULL
Minitab	NULL
computer	NULL
software	NULL
(	NULL
Clecom	NULL
,	NULL
Birmingham	NULL
,	NULL
UK	NULL
)	NULL
.	NULL

RESULTS	NULL
The	NULL
HLE	NULL
cells	NULL
rapidly	NULL
formed	NULL
confluent	NULL
monolayers	NULL
of	NULL
cells	NULL
which	NULL
showed	NULL
a	NULL
regular	NULL
cobblestone	NULL
morphology	NULL
typical	NULL
of	NULL
endothelial	NULL
cells	NULL
.	NULL

The	NULL
results	NULL
of	NULL
Western	NULL
analysis	NULL
of	NULL
protein	NULL
extracts	NULL
from	NULL
HLE	NULL
cells	NULL
are	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Resting	NULL
cells	NULL
showed	NULL
only	NULL
low-level	NULL
expression	NULL
of	NULL
STAT	NULL
but	NULL
densitometric	NULL
analysis	NULL
revealed	NULL
that	NULL
the	NULL
expression	NULL
of	NULL
this	NULL
protein	NULL
was	NULL
up-regulated	NULL
approximately	NULL
13-fold	NULL
following	NULL
stimulation	NULL
of	NULL
the	NULL
cells	NULL
with	NULL
IFN-y	NULL
.	NULL

Following	NULL
induction	NULL
with	NULL
IFN-y	NULL
it	NULL
was	NULL
clear	NULL
that	NULL
two	NULL
components	NULL
of	NULL
STAT	NULL
were	NULL
detected	NULL
by	NULL
Western	NULL
blotting	NULL
;	NULL
these	NULL
had	NULL
apparent	NULL
molecular	NULL
weights	NULL
of	NULL
91	NULL
000	NULL
and	NULL
84000	NULL
.	NULL

Significantly	NULL
,	NULL
the	NULL
up-regulation	NULL
of	NULL
STAT-1	NULL
was	NULL
not	NULL
observed	NULL
when	NULL
stimulation	NULL
with	NULL
IFN-y	NULL
was	NULL
performed	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
heparin	NULL
.	NULL

A	NULL
similar	NULL
amount	NULL
of	NULL
total	NULL
protein	NULL
was	NULL
fractionated	NULL
by	NULL
electrophoresis	NULL
in	NULL
each	NULL
case	NULL
.	NULL

Sensitive	NULL
ELISA	NULL
was	NULL
used	NULL
to	NULL
measure	NULL
the	NULL
concentration	NULL
of	NULL
MCP-1	NULL
in	NULL
matched	NULL
cultures	NULL
of	NULL
resting	NULL
and	NULL
IFN-y-stimulated	NULL
HLE	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

It	NULL
was	NULL
found	NULL
that	NULL
stimulation	NULL
for	NULL
24	NULL
hr	NULL
with	NULL
IFN-y	NULL
at	NULL
100	NULL
U/ml	NULL
increased	NULL
the	NULL
concentration	NULL
of	NULL
MCP-1	NULL
from	NULL
0-17	NULL
+0-01	NULL
ng/ml	NULL
to	NULL
1:45	NULL
+0-04	NULL
ng/ml	NULL
(	NULL
P	NULL
<	NULL
0-02	NULL
)	NULL
.	NULL

©1997	NULL
Blackwell	NULL
Science	NULL
Ltd	NULL
,	NULL
Immunology	NULL
,	NULL
92	NULL
,	NULL
512-518	NULL
Modulation	NULL
of	NULL
cytokines	NULL
by	NULL
heparin	NULL
515	NULL
1	NULL
2	NULL
3	NULL
p91	NULL
p84	NULL
Figure	NULL
1	NULL
.	NULL

Effect	NULL
on	NULL
the	NULL
expression	NULL
of	NULL
STAT-1	NULL
of	NULL
stimulation	NULL
of	NULL
endothelial	NULL
cells	NULL
with	NULL
IFN-y	NULL
.	NULL

This	NULL
Western	NULL
blot	NULL
shows	NULL
STAT-1	NULL
expression	NULL
by	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
resting	NULL
endothelial	NULL
cells	NULL
,	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
cells	NULL
stimulated	NULL
with	NULL
IFN-y	NULL
and	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
cells	NULL
stimulated	NULL
with	NULL
a	NULL
mixture	NULL
of	NULL
IFN-y	NULL
and	NULL
heparin	NULL
.	NULL

These	NULL
representative	NULL
data	NULL
are	NULL
from	NULL
one	NULL
of	NULL
three	NULL
similar	NULL
experiments	NULL
.	NULL

a	NULL
15	NULL
7	NULL
€	NULL
4	NULL
D	NULL
£	NULL
E	NULL
3	NULL
k=l	NULL
g	NULL
1-0	NULL
5	NULL
C	NULL
9	NULL
fo	NULL
§	NULL
054	NULL
o	NULL
C	NULL
8	NULL
p	NULL
o.	NULL
O	NULL
E	NULL
0	NULL
T	NULL
``	NULL
T	NULL
--	NULL
f	NULL
T	NULL
T	NULL
T	NULL
T	NULL
T	NULL
to	NULL
0	NULL
50	NULL
100	NULL
150	NULL
200	NULL
250	NULL
GAG	NULL
concentration	NULL
(	NULL
g/ml	NULL
)	NULL
Figure	NULL
2	NULL
.	NULL

The	NULL
concentration	NULL
of	NULL
MCP-1	NULL
in	NULL
variously	NULL
treated	NULL
endothelial	NULL
cell	NULL
cultures	NULL
.	NULL

The	NULL
hatched	NULL
bar	NULL
shows	NULL
the	NULL
concentration	NULL
of	NULL
MCP-1	NULL
in	NULL
the	NULL
medium	NULL
from	NULL
resting	NULL
cell	NULL
cultures	NULL
(	NULL
@	NULL
)	NULL
the	NULL
MCP-1	NULL
concentration	NULL
in	NULL
medium	NULL
from	NULL
cells	NULL
cultured	NULL
with	NULL
IFN-y	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
0-250	NULL
ug/ml	NULL
of	NULL
heparin	NULL
(	NULL
M	NULL
)	NULL
the	NULL
concentration	NULL
of	NULL
MCP-1	NULL
produced	NULL
by	NULL
IFN-y-treated	NULL
cells	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
HS	NULL
at	NULL
250	NULL
ug/ml	NULL
(	NULL
A	NULL
)	NULL
the	NULL
concentration	NULL
of	NULL
MCP-1	NULL
produced	NULL
by	NULL
cells	NULL
cultured	NULL
with	NULL
IFN-y	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
250	NULL
ug/ml	NULL
of	NULL
CS-C.	NULL
Each	NULL
point	NULL
represents	NULL
the	NULL
mean	NULL
of	NULL
triplicate	NULL
determinations	NULL
;	NULL
error	NULL
bars	NULL
show	NULL
the	NULL
SEM	NULL
.	NULL

However	NULL
,	NULL
when	NULL
similar	NULL
experiments	NULL
were	NULL
performed	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
increasing	NULL
concentrations	NULL
of	NULL
heparin	NULL
it	NULL
was	NULL
found	NULL
that	NULL
the	NULL
concentration	NULL
of	NULL
MCP-1	NULL
in	NULL
the	NULL
culture	NULL
medium	NULL
was	NULL
reduced	NULL
;	NULL
indeed	NULL
the	NULL
concentration	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
heparin	NULL
at	NULL
between	NULL
125	NULL
and	NULL
250	NULL
ug/ml	NULL
was	NULL
not	NULL
significantly	NULL
different	NULL
from	NULL
that	NULL
produced	NULL
by	NULL
resting	NULL
HLE	NULL
cells	NULL
.	NULL

A	NULL
heparin	NULL
concentration	NULL
of	NULL
16	NULL
ug/ml	NULL
blocked	NULL
more	NULL
than	NULL
half	NULL
of	NULL
the	NULL
MCP-1	NULL
induction	NULL
by	NULL
IFN-y	NULL
.	NULL

Addition	NULL
of	NULL
250	NULL
ug/ml	NULL
of	NULL
HS	NULL
also	NULL
inhibited	NULL
the	NULL
induction	NULL
of	NULL
MCP-1	NULL
by	NULL
IFN-y	NULL
but	NULL
to	NULL
a	NULL
slightly	NULL
smaller	NULL
extent	NULL
than	NULL
heparin	NULL
(	NULL
P	NULL
<	NULL
0-05	NULL
;	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

By	NULL
contrast	NULL
,	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
maximal	NULL
250	NULL
ug/ml	NULL
of	NULL
CS-C	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
production	NULL
of	NULL
MCP-1	NULL
by	NULL
IFN-y-stimulated	NULL
HLE	NULL
cells	NULL
.	NULL

Experiments	NULL
were	NULL
also	NULL
performed	NULL
to	NULL
assess	NULL
the	NULL
production	NULL
of	NULL
MCP-1	NULL
by	NULL
endothelial	NULL
cells	NULL
following	NULL
stimulation	NULL
by	NULL
a	NULL
more	NULL
physiological	NULL
source	NULL
of	NULL
proinflammatory	NULL
cytokines	NULL
.	NULL

©1997	NULL
Blackwell	NULL
Science	NULL
Ltd	NULL
,	NULL
Immunology	NULL
,	NULL
92	NULL
,	NULL
512-518	NULL
Endothelial	NULL
cell	NULL
monolayers	NULL
were	NULL
stimulated	NULL
with	NULL
either	NULL
MLR-conditioned	NULL
medium	NULL
or	NULL
normal	NULL
culture	NULL
medium	NULL
for	NULL
24	NULL
hr	NULL
,	NULL
were	NULL
then	NULL
washed	NULL
extensively	NULL
and	NULL
were	NULL
cultured	NULL
for	NULL
a	NULL
further	NULL
24	NULL
hr	NULL
in	NULL
fresh	NULL
medium	NULL
.	NULL

After	NULL
this	NULL
time	NULL
the	NULL
concentration	NULL
of	NULL
MCP-1	NULL
in	NULL
the	NULL
medium	NULL
was	NULL
measured	NULL
by	NULL
ELISA	NULL
.	NULL

It	NULL
was	NULL
found	NULL
that	NULL
cells	NULL
treated	NULL
with	NULL
normal	NULL
medium	NULL
produced	NULL
a	NULL
concentration	NULL
of	NULL
MCP-1	NULL
of	NULL
1-2+01	NULL
ng/ml	NULL
,	NULL
whilst	NULL
cells	NULL
which	NULL
had	NULL
been	NULL
pretreated	NULL
with	NULL
the	NULL
MLR	NULL
supernatant	NULL
produced	NULL
the	NULL
significantly	NULL
greater	NULL
concentration	NULL
of	NULL
11:3	NULL
+0-2	NULL
ng/ml	NULL
(	NULL
P	NULL
<	NULL
0-01	NULL
)	NULL
;	NULL
the	NULL
MLR-conditioned	NULL
medium	NULL
itself	NULL
was	NULL
found	NULL
to	NULL
contain	NULL
MCP-1	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
60+0-1	NULL
ng/ml	NULL
.	NULL

This	NULL
enhanced	NULL
production	NULL
of	NULL
MCP-1	NULL
was	NULL
not	NULL
altered	NULL
by	NULL
addition	NULL
of	NULL
250	NULL
ug/ml	NULL
of	NULL
heparin	NULL
to	NULL
the	NULL
MLR	NULL
supernatant	NULL
A	NULL
transendothelial	NULL
migration	NULL
assay	NULL
was	NULL
used	NULL
to	NULL
assess	NULL
the	NULL
migration-promoting	NULL
activity	NULL
of	NULL
MCP-1	NULL
This	NULL
assay	NULL
showed	NULL
that	NULL
relatively	NULL
few	NULL
leucocytes	NULL
in	NULL
the	NULL
resting	NULL
population	NULL
crossed	NULL
a	NULL
confluent	NULL
endothelial	NULL
cell	NULL
monolayer	NULL
during	NULL
a	NULL
3-hr	NULL
incubation	NULL
period	NULL
.	NULL

However	NULL
,	NULL
the	NULL
number	NULL
of	NULL
migrant	NULL
cells	NULL
was	NULL
increased	NULL
by	NULL
addition	NULL
of	NULL
MCP-1	NULL
to	NULL
the	NULL
lower	NULL
chamber	NULL
of	NULL
the	NULL
transwell	NULL
system	NULL
.	NULL

This	NULL
increase	NULL
reached	NULL
statistical	NULL
significance	NULL
at	NULL
an	NULL
MCP-1	NULL
concentration	NULL
of	NULL
5	NULL
ng/ml	NULL
(	NULL
P	NULL
<	NULL
0-05	NULL
)	NULL
.	NULL

A	NULL
further	NULL
increase	NULL
in	NULL
transmigration	NULL
was	NULL
observed	NULL
at	NULL
10	NULL
ng/ml	NULL
of	NULL
MCP-1	NULL
;	NULL
at	NULL
this	NULL
chemokine	NULL
concentration	NULL
the	NULL
number	NULL
of	NULL
migrant	NULL
cells	NULL
was	NULL
increased	NULL
by	NULL
almost	NULL
sevenfold	NULL
.	NULL

Some	NULL
variation	NULL
in	NULL
absolute	NULL
migration	NULL
was	NULL
observed	NULL
between	NULL
leucocytes	NULL
from	NULL
different	NULL
donors	NULL
,	NULL
but	NULL
the	NULL
pattern	NULL
of	NULL
the	NULL
chemotactic	NULL
response	NULL
remained	NULL
consistent	NULL
in	NULL
each	NULL
case	NULL
.	NULL

Western	NULL
analysis	NULL
was	NULL
used	NULL
to	NULL
assess	NULL
changes	NULL
in	NULL
the	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
PI	NULL
3-kinase	NULL
caused	NULL
by	NULL
treatment	NULL
of	NULL
freshly	NULL
isolated	NULL
mononuclear	NULL
leucocytes	NULL
with	NULL
MCP-l-for	NULL
periods	NULL
of	NULL
up	NULL
to	NULL
30	NULL
min	NULL
.	NULL

It	NULL
was	NULL
found	NULL
that	NULL
the	NULL
amount	NULL
of	NULL
phosphotyrosine	NULL
on	NULL
the	NULL
blot	NULL
at	NULL
a	NULL
position	NULL
corresponding	NULL
to	NULL
PI	NULL
3-kinase	NULL
increased	NULL
markedly	NULL
following	NULL
treatment	NULL
of	NULL
the	NULL
cells	NULL
with	NULL
MCP-1	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
15	NULL
ng/ml	NULL
.	NULL

Precise	NULL
measurement	NULL
of	NULL
relative	NULL
changes	NULL
in	NULL
the	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
PI	NULL
3-kinase	NULL
was	NULL
performed	NULL
by	NULL
calculation	NULL
of	NULL
the	NULL
densitometric	NULL
ratio	NULL
of	NULL
bands	NULL
following	NULL
serial	NULL
labelling	NULL
of	NULL
phosphotyrosine	NULL
and	NULL
PI	NULL
3-kinase	NULL
.	NULL

Figure	NULL
3	NULL
shows	NULL
that	NULL
the	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
PI	NULL
3-kinase	NULL
was	NULL
increased	NULL
after	NULL
incubation	NULL
of	NULL
the	NULL
cells	NULL
with	NULL
MCP-1	NULL
for	NULL
2:5	NULL
min	NULL
and	NULL
reached	NULL
a	NULL
maximal	NULL
1-6-fold	NULL
increase	NULL
after	NULL
incubation	NULL
for	NULL
10	NULL
min	NULL
;	NULL
after	NULL
20	NULL
min	NULL
the	NULL
proportion	NULL
of	NULL
phosphotyrosine	NULL
decreased	NULL
.	NULL

Treatment	NULL
of	NULL
mononuclear	NULL
leucocytes	NULL
with	NULL
medium	NULL
conditioned	NULL
by	NULL
MLR	NULL
supernatant-activated	NULL
endothelial	NULL
cells	NULL
also	NULL
caused	NULL
an	NULL
increase	NULL
in	NULL
the	NULL
proportion	NULL
of	NULL
phosphotyrosine	NULL
in	NULL
PI	NULL
3-kinase	NULL
.	NULL

This	NULL
was	NULL
maximal	NULL
after	NULL
15	NULL
min	NULL
and	NULL
reached	NULL
a	NULL
level	NULL
1-8	NULL
times	NULL
greater	NULL
than	NULL
that	NULL
in	NULL
resting	NULL
cells	NULL
.	NULL

A	NULL
series	NULL
of	NULL
experiments	NULL
was	NULL
performed	NULL
to	NULL
determine	NULL
whether	NULL
heparin	NULL
could	NULL
directly	NULL
antagonize	NULL
the	NULL
activity	NULL
of	NULL
MCP-1	NULL
.	NULL

It	NULL
was	NULL
found	NULL
that	NULL
pretreatment	NULL
of	NULL
MCP	NULL
-1	NULL
with	NULL
heparin	NULL
resulted	NULL
in	NULL
a	NULL
66	NULL
%	NULL
blockade	NULL
of	NULL
the	NULL
potential	NULL
MCP	NULL
--	NULL
mediated	NULL
increase	NULL
in	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
leucocyte	NULL
PI	NULL
3-kinase	NULL
(	NULL
Fig	NULL
.	NULL

4a	NULL
)	NULL
;	NULL
beparin	NULL
alone	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
resting	NULL
level	NULL
of	NULL
phosphotyrosine	NULL
in	NULL
PI	NULL
3-kinase	NULL
.	NULL

A	NULL
similar	NULL
antagonism	NULL
of	NULL
this	NULL
MCP-1	NULL
activity	NULL
was	NULL
not	NULL
produced	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
CS-C	NULL
.	NULL

These	NULL
results	NULL
were	NULL
paralleled	NULL
by	NULL
the	NULL
observation	NULL
that	NULL
heparin	NULL
pre-treated	NULL
MCP-1	NULL
did	NULL
not	NULL
stimulate	NULL
mononuclear	NULL
cell	NULL
migration	NULL
across	NULL
endothelial	NULL
cell	NULL
monolayers	NULL
to	NULL
a	NULL
greater	NULL
extent	NULL
than	NULL
normal	NULL
culture	NULL
medium	NULL
(	NULL
Fig	NULL
.	NULL

4b	NULL
)	NULL
.	NULL

As	NULL
with	NULL
the	NULL
PI	NULL
3-kinase	NULL
data	NULL
,	NULL
CS-C	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
migration-promoting	NULL
activity	NULL
of	NULL
MCP-1	NULL
.	NULL

The	NULL
medium	NULL
conditioned	NULL
by	NULL
endothelial	NULL
cells	NULL
which	NULL
had	NULL
516	NULL
M.	NULL
S.	NULL
Douglas	NULL
et	NULL
al	NULL
.	NULL

0	NULL
17	NULL
7	NULL
fo	NULL
|	NULL
z	NULL
1-6	NULL
-	NULL
7	NULL
5	NULL
15	NULL
4	NULL
2	NULL
.	NULL

‘	NULL
l'4T	NULL
ts	NULL
|	NULL
2	NULL
o	NULL
1	NULL
&	NULL
9	NULL
I	NULL
g.	NULL
12	NULL
.	NULL

&	NULL
10	NULL
i	NULL
1D	NULL
121	NULL
¢	NULL
,	NULL
LA	NULL
H	NULL
H	NULL
UH	NULL
U	NULL
U	NULL
0	NULL
25	NULL
5	NULL
10	NULL
20	NULL
30	NULL
Length	NULL
of	NULL
stimulation	NULL
time	NULL
(	NULL
min	NULL
)	NULL
Figure	NULL
3	NULL
.	NULL

The	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
PI	NULL
3-kinase	NULL
at	NULL
increasing	NULL
time-points	NULL
following	NULL
stimulation	NULL
of	NULL
mononuclear	NULL
leucocytes	NULL
with	NULL
MCP-1	NULL
.	NULL

Densitometric	NULL
analysis	NULL
of	NULL
Western	NULL
blots	NULL
revealed	NULL
changes	NULL
in	NULL
the	NULL
relative	NULL
proportion	NULL
of	NULL
phosphotyrosine	NULL
residues	NULL
in	NULL
PI	NULL
3-kinase	NULL
following	NULL
stimulation	NULL
with	NULL
MCP-1	NULL
for	NULL
0	NULL
,	NULL
2:5	NULL
,	NULL
5	NULL
,	NULL
10	NULL
,	NULL
20	NULL
and	NULL
30	NULL
min	NULL
.	NULL

These	NULL
representative	NULL
results	NULL
are	NULL
from	NULL
one	NULL
of	NULL
three	NULL
similar	NULL
experiments	NULL
.	NULL

been	NULL
pre-activated	NULL
by	NULL
treatment	NULL
with	NULL
an	NULL
MLR	NULL
supernatant	NULL
stimulated	NULL
a	NULL
mean	NULL
2-9-fold	NULL
increase	NULL
in	NULL
mononuclear	NULL
cell	NULL
transendothelial	NULL
migration	NULL
(	NULL
P	NULL
<	NULL
0-03	NULL
)	NULL
.	NULL

Addition	NULL
of	NULL
heparin	NULL
to	NULL
the	NULL
conditioned	NULL
medium	NULL
reduced	NULL
this	NULL
migratory	NULL
response	NULL
by	NULL
85	NULL
%	NULL
;	NULL
CS-C	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
enhanced	NULL
mononuclear	NULL
cell	NULL
migration	NULL
.	NULL

DISCUSSION	NULL
The	NULL
cultured	NULL
cells	NULL
displayed	NULL
morphological	NULL
features	NULL
of	NULL
endothelium	NULL
and	NULL
were	NULL
shown	NULL
to	NULL
express	NULL
a	NULL
characteristic	NULL
range	NULL
of	NULL
endothelial	NULL
cell	NULL
markers	NULL
.	NULL

Routine	NULL
culture	NULL
was	NULL
performed	NULL
in	NULL
heparin-free	NULL
medium	NULL
in	NULL
order	NULL
to	NULL
prevent	NULL
carry-over	NULL
and	NULL
potential	NULL
interference	NULL
with	NULL
the	NULL
assays	NULL
of	NULL
cytokine	NULL
function	NULL
.	NULL

It	NULL
has	NULL
already	NULL
been	NULL
established	NULL
clearly	NULL
that	NULL
low	NULL
concentrations	NULL
of	NULL
heparin	NULL
can	NULL
antagonize	NULL
the	NULL
capacity	NULL
of	NULL
IFN-y	NULL
to	NULL
induce	NULL
endothelial	NULL
class	NULL
II	NULL
MHC	NULL
antigens	NULL
and	NULL
to	NULL
up-regulate	NULL
the	NULL
expression	NULL
of	NULL
ICAM-1	NULL
.	NULL
``	NULL

Signal	NULL
transduction	NULL
from	NULL
the	NULL
specific	NULL
IFN-y	NULL
receptor	NULL
complex	NULL
involves	NULL
rapid	NULL
phosphorylation	NULL
of	NULL
STAT-1	NULL
and	NULL
a	NULL
more	NULL
gradual	NULL
increase	NULL
in	NULL
the	NULL
level	NULL
of	NULL
intracellular	NULL
STAT-1	NULL
expression	NULL
.	NULL
``	NULL

STAT-1	NULL
exists	NULL
as	NULL
splice-variant	NULL
a-	NULL
and	NULL
B-isoforms	NULL
which	NULL
have	NULL
characteristic	NULL
molecular	NULL
weights	NULL
of	NULL
91	NULL
and	NULL
84	NULL
kDa	NULL
,	NULL
respectively	NULL
.	NULL

As	NULL
with	NULL
most	NULL
cells	NULL
,	NULL
``	NULL
the	NULL
endothelial	NULL
cells	NULL
used	NULL
in	NULL
the	NULL
current	NULL
study	NULL
contained	NULL
significantly	NULL
more	NULL
STAT-l	NULL
«	NULL
than	NULL
the	NULL
B-isoform	NULL
.	NULL

Phosphorylated	NULL
STAT-1	NULL
forms	NULL
a	NULL
dimer	NULL
which	NULL
migrates	NULL
to	NULL
the	NULL
nucleus	NULL
and	NULL
activates	NULL
transcription	NULL
by	NULL
binding	NULL
to	NULL
an	NULL
IFN-y-activated	NULL
sequence	NULL
of	NULL
DNA	NULL
.	NULL
``	NULL

The	NULL
ICAM-1	NULL
gene	NULL
is	NULL
known	NULL
to	NULL
contain	NULL
such	NULL
a	NULL
sequence	NULL
that	NULL
can	NULL
stimulate	NULL
rapid	NULL
up-regulation	NULL
of	NULL
expression	NULL
,	NULL
but	NULL
the	NULL
more	NULL
gradual	NULL
induction	NULL
of	NULL
class	NULL
II	NULL
MHC	NULL
antigens	NULL
by	NULL
IFN-y	NULL
is	NULL
thought	NULL
to	NULL
be	NULL
dependent	NULL
on	NULL
an	NULL
increase	NULL
in	NULL
the	NULL
level	NULL
of	NULL
STAT-1	NULL
.	NULL

*	NULL
The	NULL
observation	NULL
that	NULL
addition	NULL
of	NULL
heparin	NULL
to	NULL
IFN-y	NULL
blocks	NULL
the	NULL
activation	NULL
of	NULL
STAT-1	NULL
is	NULL
consistent	NULL
with	NULL
previous	NULL
reports	NULL
that	NULL
heparin	NULL
antagonizes	NULL
the	NULL
capacity	NULL
of	NULL
IFN-y	NULL
for	NULL
up-regulation	NULL
of	NULL
endothelial	NULL
ICAM-1	NULL
expression	NULL
``	NULL
and	NULL
for	NULL
the	NULL
induction	NULL
of	NULL
class	NULL
II	NULL
MHC	NULL
antigens	NULL
.	NULL
'	NULL

''	NULL
``	NULL
``	NULL
This	NULL
supports	NULL
the	NULL
(	NULL
a	NULL
)	NULL
.0	NULL
©	NULL
o	NULL
157	NULL
8	NULL
14	NULL
!	NULL

F	NULL
7	NULL
14	NULL
§	NULL
|	NULL
co	NULL
3	NULL
I	NULL
m	NULL
-	NULL
123	NULL
29	NULL
2	NULL
2	NULL
1741	NULL
1	NULL
a	NULL
.	NULL

8	NULL
|	NULL
%	NULL
E=	NULL
10	NULL
+~-	NULL
--	NULL
-	NULL
~~~	NULL
Ab-	NULL
--	NULL
-	NULL
-	NULL
-	NULL
~Wh	NULL
l=	NULL
-	NULL
cos	NULL
2	NULL
--	NULL
a	NULL
-_	NULL
I|	NULL
FA	NULL
FA	NULL
1221	NULL
i	NULL
.LA	NULL
_	NULL
WH	NULL
___A	NULL
UZ	NULL
C	NULL
Medium	NULL
MCP-1	NULL
MCP-1+	NULL
_	NULL
MCP-1+	NULL
heparin	NULL
CS-C	NULL
Treatment	NULL
of	NULL
PBMC	NULL
(	NULL
b	NULL
)	NULL
C	NULL
257	NULL
tJ	NULL
C	NULL
$	NULL
20	NULL
A	NULL
3	NULL
0	NULL
o	NULL
154	NULL
2	NULL
<	NULL
®	NULL
&	NULL
1-0	NULL
+	NULL
--	NULL
rriwmm	NULL
--	NULL
--	NULL
--	NULL
GWife	NULL
c-	NULL
--	NULL
-	NULL
>	NULL
--	NULL
-	NULL
--	NULL
--	NULL
-5	NULL
F	NULL
o	NULL
5	NULL
05	NULL
E	NULL
2	NULL
o	NULL
i-	NULL
I	NULL
I	NULL
I	NULL
T	NULL
Medium	NULL
MCP-1	NULL
MCP-1+	NULL
_	NULL
MCP-1+	NULL
heparin	NULL
CS-C	NULL
Migratory	NULL
stimulus	NULL
Figure	NULL
4	NULL
.	NULL

Effect	NULL
of	NULL
mixture	NULL
of	NULL
MCP-1	NULL
with	NULL
GAGs	NULL
on	NULL
mononuclear	NULL
leucocyte	NULL
activation	NULL
and	NULL
transendothelial	NULL
migration	NULL
.	NULL

(	NULL
a	NULL
)	NULL
Relative	NULL
proportion	NULL
of	NULL
phosphotyrosine	NULL
residues	NULL
in	NULL
mononuclear	NULL
cell	NULL
PI	NULL
3-kinase	NULL
following	NULL
treatment	NULL
with	NULL
MCP-1	NULL
,	NULL
MCP-1	NULL
mixed	NULL
with	NULL
heparin	NULL
,	NULL
and	NULL
MCP-1	NULL
mixed	NULL
with	NULL
CS-C	NULL
;	NULL
these	NULL
representative	NULL
results	NULL
are	NULL
from	NULL
one	NULL
of	NULL
three	NULL
similar	NULL
experiments	NULL
.	NULL

(	NULL
b	NULL
)	NULL
Transendothelial	NULL
migration	NULL
of	NULL
mononuclear	NULL
leucocytes	NULL
stimulated	NULL
with	NULL
MCP-1	NULL
,	NULL
MCP-1	NULL
mixed	NULL
with	NULL
heparin	NULL
,	NULL
and	NULL
MCP-1	NULL
mixed	NULL
with	NULL
CS-C.	NULL
Each	NULL
point	NULL
represents	NULL
the	NULL
mean	NULL
of	NULL
triplicate	NULL
determinations	NULL
;	NULL
error	NULL
bars	NULL
show	NULL
the	NULL
SEM	NULL
.	NULL

notion	NULL
that	NULL
heparin	NULL
binds	NULL
to	NULL
IFN-y	NULL
and	NULL
inhibits	NULL
normal	NULL
sequestration	NULL
onto	NULL
the	NULL
endothelial	NULL
cell	NULL
surface	NULL
;	NULL
*	NULL
``	NULL
this	NULL
prevents	NULL
interaction	NULL
with	NULL
the	NULL
specific	NULL
receptor	NULL
and	NULL
initiation	NULL
of	NULL
the	NULL
signal	NULL
transduction	NULL
pathway	NULL
.	NULL

The	NULL
production	NULL
of	NULL
MCP-1	NULL
is	NULL
increased	NULL
by	NULL
a	NULL
wide	NULL
range	NULL
of	NULL
specific	NULL
and	NULL
non-specific	NULL
stimuli	NULL
;	NULL
*	NULL
``	NULL
most	NULL
of	NULL
these	NULL
effects	NULL
are	NULL
mediated	NULL
by	NULL
increases	NULL
in	NULL
gene	NULL
transcription	NULL
following	NULL
binding	NULL
of	NULL
proteins	NULL
such	NULL
as	NULL
nuclear	NULL
factor-xB	NULL
.	NULL

``	NULL
°	NULL
The	NULL
up-regulation	NULL
of	NULL
MCP-1	NULL
production	NULL
by	NULL
HLE	NULL
cells	NULL
following	NULL
stimulation	NULL
by	NULL
IFN-y	NULL
is	NULL
consistent	NULL
with	NULL
results	NULL
from	NULL
a	NULL
previous	NULL
study	NULL
of	NULL
microvascular	NULL
endothelial	NULL
cells	NULL
.	NULL
``	NULL

Study	NULL
of	NULL
the	NULL
effect	NULL
of	NULL
GAG	NULL
molecules	NULL
on	NULL
this	NULL
activity	NULL
of	NULL
IFN-y	NULL
showed	NULL
that	NULL
the	NULL
related	NULL
molecules	NULL
heparin	NULL
and	NULL
HS	NULL
were	NULL
antagonistic	NULL
but	NULL
the	NULL
structurally	NULL
dissimilar	NULL
GAG	NULL
,	NULL
CS-C	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
MCP-1	NULL
up-regulation	NULL
.	NULL

This	NULL
is	NULL
consistent	NULL
with	NULL
previous	NULL
studies	NULL
which	NULL
show	NULL
that	NULL
CS-C	NULL
neither	NULL
binds	NULL
IFN-y	NULL
(	NULL
MSD/JAK	NULL
,	NULL
unpublished	NULL
observations	NULL
)	NULL
nor	NULL
inhibits	NULL
the	NULL
binding	NULL
of	NULL
this	NULL
cytokine	NULL
©1997	NULL
Blackwell	NULL
Science	NULL
Ltd	NULL
,	NULL
Immunology	NULL
,	NULL
92	NULL
,	NULL
512-518	NULL
Modulation	NULL
of	NULL
cytokines	NULL
by	NULL
heparin	NULL
517	NULL
to	NULL
endothelial	NULL
cells	NULL
.	NULL
``	NULL

The	NULL
concentration	NULL
of	NULL
heparin	NULL
required	NULL
to	NULL
block	NULL
50	NULL
%	NULL
of	NULL
the	NULL
MCP-1	NULL
response	NULL
to	NULL
high-dose	NULL
IFN-y	NULL
is	NULL
similar	NULL
to	NULL
the	NULL
plasma	NULL
concentration	NULL
of	NULL
greater	NULL
than	NULL
10	NULL
ug/ml	NULL
that	NULL
can	NULL
be	NULL
attained	NULL
easily	NULL
after	NULL
intravenous	NULL
heparin	NULL
injection	NULL
.	NULL
``	NULL

''	NULL
During	NULL
the	NULL
MLR	NULL
,	NULL
allospecific	NULL
T	NULL
cells	NULL
produce	NULL
a	NULL
range	NULL
of	NULL
proinflammatory	NULL
cytokines	NULL
,	NULL
including	NULL
IFN-y	NULL
and	NULL
tumour	NULL
necrosis	NULL
factor-	NULL
«	NULL
(	NULL
TNF-	NULL
«	NULL
)	NULL
;	NULL
*°	NULL
these	NULL
cytokines	NULL
stimulated	NULL
HLE	NULL
cells	NULL
to	NULL
increase	NULL
production	NULL
of	NULL
MCP-1	NULL
.	NULL

Unlike	NULL
the	NULL
induction	NULL
of	NULL
class	NULL
II	NULL
MHC	NULL
antigens	NULL
,	NULL
which	NULL
requires	NULL
chronic	NULL
cytokine	NULL
stimulation	NULL
,	NULL
``	NULL
the	NULL
production	NULL
of	NULL
MCP	NULL
was	NULL
maintained	NULL
following	NULL
removal	NULL
of	NULL
the	NULL
MLR	NULL
conditioned	NULL
medium	NULL
.	NULL

Addition	NULL
of	NULL
heparin	NULL
to	NULL
the	NULL
MLR	NULL
supernatant	NULL
did	NULL
not	NULL
affect	NULL
the	NULL
enhanced	NULL
production	NULL
of	NULL
MCP-1	NULL
by	NULL
stimulated	NULL
endothelial	NULL
cells	NULL
.	NULL

This	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
observation	NULL
that	NULL
TNF-4	NULL
,	NULL
which	NULL
is	NULL
known	NULL
to	NULL
augment	NULL
MCP-1	NULL
production	NULL
by	NULL
endothelial	NULL
cells	NULL
,	NULL
``	NULL
``	NULL
is	NULL
not	NULL
inhibited	NULL
by	NULL
heparin	NULL
.	NULL
``	NULL

Mononuclear	NULL
cell	NULL
migration	NULL
assays	NULL
showed	NULL
that	NULL
the	NULL
concentration	NULL
of	NULL
chemotactic	NULL
cytokines	NULL
generated	NULL
by	NULL
stimulation	NULL
of	NULL
HLE	NULL
cells	NULL
with	NULL
MLR	NULL
supernatants	NULL
was	NULL
sufficient	NULL
to	NULL
stimulate	NULL
a	NULL
markedly	NULL
increased	NULL
passage	NULL
of	NULL
leucocytes	NULL
across	NULL
confluent	NULL
endothelial	NULL
cell	NULL
monolayers	NULL
;	NULL
this	NULL
chemotactic	NULL
activity	NULL
was	NULL
inhibited	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
heparin-like	NULL
GAGs	NULL
.	NULL

This	NULL
observation	NULL
is	NULL
consistent	NULL
with	NULL
functional	NULL
blockade	NULL
of	NULL
heparin-binding	NULL
chemotactic	NULL
molecules	NULL
of	NULL
endothelial	NULL
origin	NULL
,	NULL
such	NULL
as	NULL
MCP-1	NULL
,	NULL
by	NULL
a	NULL
mechanism	NULL
analogous	NULL
to	NULL
that	NULL
proposed	NULL
for	NULL
IFN-y	NULL
.	NULL

Variation	NULL
in	NULL
the	NULL
overall	NULL
chemotactic	NULL
response	NULL
to	NULL
MCP-1	NULL
observed	NULL
in	NULL
different	NULL
experiments	NULL
is	NULL
consistent	NULL
with	NULL
previous	NULL
reports	NULL
and	NULL
may	NULL
reflect	NULL
leucocyte	NULL
subset	NULL
variation	NULL
between	NULL
donors	NULL
or	NULL
perhaps	NULL
inter-donor	NULL
differences	NULL
in	NULL
chemokine	NULL
receptor	NULL
expression	NULL
.	NULL
``	NULL

''	NULL
Treatment	NULL
of	NULL
T	NULL
cells	NULL
with	NULL
the	NULL
chemokine	NULL
RANTES	NULL
produces	NULL
an	NULL
increase	NULL
in	NULL
the	NULL
kinase	NULL
activity	NULL
of	NULL
immunoprecipit-ated	NULL
PI	NULL
3-kinase	NULL
.	NULL

``	NULL
°	NULL
PI	NULL
3-kinase	NULL
is	NULL
a	NULL
heterodimer	NULL
consisting	NULL
of	NULL
85000	NULL
and	NULL
110000	NULL
subunits	NULL
.	NULL

The	NULL
regulatory	NULL
85	NULL
000	NULL
MW	NULL
component	NULL
can	NULL
interact	NULL
with	NULL
many	NULL
receptors	NULL
and	NULL
is	NULL
known	NULL
to	NULL
undergo	NULL
tyrosine	NULL
phosphorylation	NULL
during	NULL
stimulation	NULL
by	NULL
a	NULL
range	NULL
of	NULL
cytokines	NULL
,	NULL
``	NULL
``	NULL
but	NULL
the	NULL
relationship	NULL
between	NULL
this	NULL
phosphorylation	NULL
and	NULL
changes	NULL
in	NULL
catalytic	NULL
activity	NULL
is	NULL
unclear	NULL
.	NULL

In	NULL
the	NULL
current	NULL
study	NULL
it	NULL
was	NULL
shown	NULL
that	NULL
PI	NULL
3-kinase	NULL
phosphorylation	NULL
reached	NULL
a	NULL
maximal	NULL
level	NULL
after	NULL
mononuclear	NULL
cell	NULL
stimulation	NULL
with	NULL
MCP-1	NULL
for	NULL
10	NULL
min	NULL
;	NULL
this	NULL
is	NULL
similar	NULL
to	NULL
the	NULL
time-course	NULL
reported	NULL
for	NULL
the	NULL
increase	NULL
in	NULL
PI	NULL
3-kinase	NULL
activity	NULL
following	NULL
stimulation	NULL
with	NULL
RANTES	NULL
.	NULL

*°	NULL
It	NULL
has	NULL
been	NULL
reported	NULL
that	NULL
both	NULL
IFN-y	NULL
``	NULL
and	NULL
members	NULL
of	NULL
the	NULL
chemokine	NULL
family©	NULL
contain	NULL
polycationic	NULL
sequence	NULL
domains	NULL
which	NULL
bind	NULL
to	NULL
negatively	NULL
charged	NULL
heparin	NULL
and	NULL
HS	NULL
molecules	NULL
.	NULL

It	NULL
is	NULL
known	NULL
that	NULL
sequestration	NULL
of	NULL
IFN-y	NULL
by	NULL
cell-surface	NULL
HS	NULL
is	NULL
necessary	NULL
for	NULL
full	NULL
biological	NULL
activity	NULL
of	NULL
this	NULL
cytokine	NULL
.	NULL
``	NULL

Further	NULL
studies	NULL
indicate	NULL
that	NULL
a	NULL
similar	NULL
process	NULL
plays	NULL
a	NULL
role	NULL
in	NULL
the	NULL
function	NULL
of	NULL
B-chemokines	NULL
such	NULL
as	NULL
MIP-1	NULL
,	NULL
*	NULL
``	NULL
RANTES	NULL
,	NULL
and	NULL
of	NULL
the	NULL
«	NULL
-chemokine	NULL
IP-10	NULL
.	NULL
``	NULL

''	NULL
Direct	NULL
binding	NULL
studies	NULL
have	NULL
been	NULL
hindered	NULL
by	NULL
spontaneous	NULL
chemokine	NULL
aggregation	NULL
.	NULL
``	NULL

Significantly	NULL
,	NULL
it	NULL
has	NULL
been	NULL
demonstrated	NULL
that	NULL
soluble	NULL
heparin	NULL
can	NULL
inhibit	NULL
the	NULL
pro-adhesive	NULL
function	NULL
of	NULL
RANTES	NULL
and	NULL
MIP-1	NULL
B	NULL
but	NULL
,	NULL
paradoxically	NULL
,	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
«	NULL
-chemokine	NULL
,	NULL
IL-8	NULL
is	NULL
enhanced	NULL
by	NULL
the	NULL
presence	NULL
of	NULL
this	NULL
GAG	NULL
.	NULL

*°	NULL
In	NULL
the	NULL
current	NULL
study	NULL
it	NULL
was	NULL
shown	NULL
that	NULL
heparin	NULL
inhibited	NULL
the	NULL
activity	NULL
of	NULL
IFN-y	NULL
and	NULL
prevented	NULL
signal	NULL
transduction	NULL
from	NULL
the	NULL
membrane-associated	NULL
receptor	NULL
complex	NULL
.	NULL

Amongst	NULL
the	NULL
effects	NULL
of	NULL
IFN-y	NULL
that	NULL
are	NULL
blocked	NULL
is	NULL
the	NULL
normal	NULL
up-regulation	NULL
of	NULL
MCP-1	NULL
production	NULL
by	NULL
microvascular	NULL
endothelial	NULL
cells	NULL
.	NULL

It	NULL
©1997	NULL
Blackwell	NULL
Science	NULL
Ltd	NULL
,	NULL
Immunology	NULL
,	NULL
92	NULL
,	NULL
512-518	NULL
was	NULL
also	NULL
shown	NULL
that	NULL
mixture	NULL
of	NULL
heparin	NULL
and	NULL
MCP-1	NULL
prior	NULL
to	NULL
incubation	NULL
with	NULL
mononuclear	NULL
leucocytes	NULL
effectively	NULL
antagonized	NULL
the	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
PI	NULL
3-kinase	NULL
produced	NULL
by	NULL
MCP-1	NULL
alone	NULL
;	NULL
the	NULL
non-cytokine	NULL
binding	NULL
GAG	NULL
,	NULL
CS-C	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
this	NULL
activity	NULL
of	NULL
MCP-1	NULL
.	NULL

The	NULL
results	NULL
of	NULL
these	NULL
experiments	NULL
were	NULL
paralleled	NULL
by	NULL
those	NULL
from	NULL
studies	NULL
of	NULL
the	NULL
effect	NULL
of	NULL
adding	NULL
GAGs	NULL
to	NULL
MCP-1	NULL
in	NULL
mononuclear	NULL
cell	NULL
transendothelial	NULL
migration	NULL
assays	NULL
that	NULL
also	NULL
demonstrated	NULL
an	NULL
inhibitory	NULL
effect	NULL
that	NULL
was	NULL
specific	NULL
for	NULL
heparin	NULL
.	NULL

These	NULL
data	NULL
support	NULL
the	NULL
notion	NULL
that	NULL
activation	NULL
of	NULL
PI	NULL
3-kinase	NULL
during	NULL
MCP-1	NULL
signal	NULL
transduction	NULL
is	NULL
a	NULL
necessary	NULL
requirement	NULL
for	NULL
effective	NULL
leucocyte	NULL
activation	NULL
.	NULL

This	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
results	NULL
of	NULL
previous	NULL
studies	NULL
which	NULL
show	NULL
that	NULL
MCP-1	NULL
can	NULL
costimulate	NULL
T-cell	NULL
proliferation	NULL
,	NULL
*	NULL
``	NULL
and	NULL
that	NULL
blockade	NULL
of	NULL
the	NULL
activity	NULL
of	NULL
PI	NULL
3-kinase	NULL
with	NULL
the	NULL
fungal	NULL
metabolite	NULL
,	NULL
wortmannin	NULL
inhibits	NULL
both	NULL
T-cell	NULL
costimulation*®	NULL
and	NULL
the	NULL
normal	NULL
T-cell	NULL
chemotactic	NULL
response	NULL
induced	NULL
by	NULL
RANTES	NULL
.	NULL
``	NULL

Additional	NULL
experiments	NULL
showed	NULL
that	NULL
heparin	NULL
could	NULL
also	NULL
inhibit	NULL
the	NULL
chemotactic	NULL
activity	NULL
of	NULL
factors	NULL
,	NULL
including	NULL
MCP-1	NULL
,	NULL
that	NULL
are	NULL
released	NULL
by	NULL
endothelial	NULL
cells	NULL
that	NULL
have	NULL
been	NULL
activated	NULL
by	NULL
the	NULL
proinflammatory	NULL
cytokines	NULL
produced	NULL
by	NULL
specific	NULL
,	NULL
antigen-activated	NULL
T	NULL
lymphocytes	NULL
.	NULL

These	NULL
results	NULL
may	NULL
help	NULL
to	NULL
explain	NULL
the	NULL
basis	NULL
for	NULL
the	NULL
immunosuppressive	NULL
activity	NULL
of	NULL
heparin	NULL
that	NULL
has	NULL
been	NULL
observed	NULL
in	NULL
vivo	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
The	NULL
authors	NULL
are	NULL
grateful	NULL
to	NULL
Drs	NULL
Lise	NULL
Binderup	NULL
and	NULL
Anni	NULL
Larnkjaer	NULL
of	NULL
Leo	NULL
Pharmaceutical	NULL
Products	NULL
Ltd	NULL
,	NULL
Copenhagen	NULL
,	NULL
Denmark	NULL
for	NULL
the	NULL
kind	NULL
provision	NULL
of	NULL
heparan	NULL
sulphate	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
grants	NULL
from	NULL
the	NULL
British	NULL
Heart	NULL
Foundation	NULL
and	NULL
the	NULL
Northern	NULL
Counties	NULL
Kidney	NULL
Research	NULL
Fund	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

FaRRAR	NULL
M.A	NULL
.	NULL

&	NULL
ScHriEBER	NULL
R.D	NULL
.	NULL

(	NULL
993	NULL
)	NULL
The	NULL
molecular	NULL
cell	NULL
biology	NULL
of	NULL
interferon-y	NULL
and	NULL
its	NULL
receptor	NULL
.	NULL

Annu	NULL
Rev	NULL
Immunol	NULL
11	NULL
,	NULL
571	NULL
.	NULL

2	NULL
.	NULL

Savace	NULL
C.O.S	NULL
.	NULL

,	NULL
Hugxes	NULL
C.C.W	NULL
.	NULL

,	NULL
McintyrE	NULL
B.W	NULL
.	NULL

,	NULL
Picarp	NULL
J.K.	NULL
&	NULL
Poser	NULL
J.S	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Human	NULL
CD4*	NULL
T	NULL
cells	NULL
proliferate	NULL
to	NULL
HLA-DR	NULL
*	NULL
allogeneic	NULL
vascular	NULL
endothelium	NULL
.	NULL

Transplantation	NULL
56	NULL
,	NULL
128	NULL
.	NULL

3	NULL
.	NULL

Poser	NULL
J.S	NULL
.	NULL

,	NULL
GIMBRONE	NULL
M.A	NULL
.	NULL

,	NULL
LAPIERRE	NULL
L.A.	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
Overlapping	NULL
patterns	NULL
of	NULL
activation	NULL
of	NULL
human	NULL
endothelial	NULL
cells	NULL
by	NULL
interleukin	NULL
1	NULL
,	NULL
tumor	NULL
necrosis	NULL
factor	NULL
,	NULL
and	NULL
immune	NULL
interferon	NULL
.	NULL

J	NULL
Immunol	NULL
137	NULL
,	NULL
1893	NULL
.	NULL

4	NULL
.	NULL

Lee	NULL
Y.-J	NULL
.	NULL

&	NULL
Benveniste	NULL
EN	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Statla	NULL
expression	NULL
is	NULL
involved	NULL
in	NULL
IFN-y	NULL
induction	NULL
of	NULL
the	NULL
class	NULL
II	NULL
transactivator	NULL
and	NULL
class	NULL
II	NULL
MHC	NULL
genes	NULL
.	NULL

J	NULL
Immunol	NULL
157	NULL
,	NULL
1559	NULL
.	NULL

5	NULL
.	NULL

KJELLEN	NULL
L.	NULL
&	NULL
LinpakL	NULL
U	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Proteoglycans	NULL
:	NULL
structures	NULL
and	NULL
interactions	NULL
.	NULL

Annu	NULL
Rev	NULL
Biochem	NULL
60	NULL
,	NULL
443	NULL
.	NULL

6	NULL
.	NULL

Witt	NULL
D.P	NULL
.	NULL

&	NULL
LanpeR	NULL
A.D.	NULL
(	NULL
1994	NULL
)	NULL
Differential	NULL
binding	NULL
of	NULL
chemokines	NULL
to	NULL
glycosaminoglycan	NULL
subpopulations	NULL
.	NULL

Curr	NULL
Biol	NULL
4	NULL
,	NULL
394	NULL
.	NULL

7	NULL
.	NULL

Riper	NULL
C.C	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Many	NULL
cytokines	NULL
and	NULL
interleukins	NULL
bind	NULL
to	NULL
glycosaminoglycans	NULL
.	NULL

Immunol	NULL
Today	NULL
14	NULL
,	NULL
615	NULL
.	NULL

8	NULL
.	NULL

Lantz	NULL
M.	NULL
,	NULL
THyset	NULL
H.	NULL
,	NULL
Niusson	NULL
E.	NULL
&	NULL
Orsson	NULL
I	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
On	NULL
the	NULL
binding	NULL
of	NULL
tumour	NULL
necrosis	NULL
factor	NULL
(	NULL
TNF	NULL
)	NULL
to	NULL
heparin	NULL
and	NULL
the	NULL
release	NULL
in	NULL
vivo	NULL
of	NULL
the	NULL
TNF-binding	NULL
protein	NULL
I	NULL
by	NULL
heparin	NULL
.	NULL

J	NULL
Clin	NULL
Invest	NULL
88	NULL
,	NULL
2026	NULL
.	NULL

9	NULL
.	NULL

Lortat-Jacos	NULL
H.	NULL
&	NULL
Grimaup	NULL
J.A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Binding	NULL
of	NULL
interferon-gamma	NULL
to	NULL
heparan	NULL
sulfate	NULL
is	NULL
restricted	NULL
to	NULL
the	NULL
heparin-like	NULL
domains	NULL
and	NULL
involves	NULL
carboxylic	NULL
-	NULL
but	NULL
not	NULL
N-sulfated	NULL
-	NULL
groups	NULL
.	NULL

Biochim	NULL
Biophys	NULL
Acta	NULL
1117	NULL
,	NULL
126	NULL
.	NULL

10	NULL
.	NULL

KoruipaRa	NULL
L.V.P	NULL
.	NULL

,	NULL
Preass	NULL
H.C.C	NULL
.	NULL

,	NULL
TaytoR®	NULL
R.M.R	NULL
.	NULL

,	NULL
ForsytaE	NULL
J.LR	NULL
.	NULL

,	NULL
Proup	NULL
G.	NULL
&	NULL
Kirsy	NULL
J.A	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Cultured	NULL
endothelium	NULL
:	NULL
518	NULL
11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24.	NULL
heparin	NULL
antagonises	NULL
the	NULL
induction	NULL
of	NULL
Class	NULL
II	NULL
molecules	NULL
by	NULL
interferon-y	NULL
.	NULL

Transplantation	NULL
58	NULL
,	NULL
1426	NULL
.	NULL

Rix	NULL
D.A	NULL
.	NULL

,	NULL
DouaLas	NULL
M.S	NULL
.	NULL

,	NULL
TacBot	NULL
D.	NULL
,	NULL
DARK	NULL
J.H	NULL
.	NULL

&	NULL
KirBy	NULL
J.A	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Role	NULL
of	NULL
glycosaminoglycans	NULL
in	NULL
regulation	NULL
of	NULL
the	NULL
immunogenicity	NULL
of	NULL
human	NULL
vascular	NULL
endothelial	NULL
cells	NULL
.	NULL

Clin	NULL
Exp	NULL
Immuno	NULL
!	NULL

104	NULL
,	NULL
60	NULL
.	NULL

W.	NULL
,	NULL
NockemaNnNn	NULL
S.	NULL
,	NULL
GutscHeE	NULL
M.	NULL
&	NULL
Hapoms	NULL
U	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Heparin	NULL
inhibits	NULL
the	NULL
antiparasitic	NULL
and	NULL
immune	NULL
modulatory	NULL
effects	NULL
of	NULL
human	NULL
recombinant	NULL
interferon-y	NULL
.	NULL

Eur	NULL
J	NULL
Immunol	NULL
25	NULL
,	NULL
688	NULL
.	NULL

Lmer	NULL
O.	NULL
,	NULL
BAHARAYV	NULL
E.	NULL
,	NULL
MEkoRI	NULL
Y.A	NULL
.	NULL

et	NULL
al	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Suppression	NULL
of	NULL
experimental	NULL
autoimmune	NULL
diseases	NULL
and	NULL
prolongation	NULL
of	NULL
allograft	NULL
survival	NULL
by	NULL
treatment	NULL
of	NULL
animals	NULL
with	NULL
low	NULL
doses	NULL
of	NULL
heparins	NULL
.	NULL

J	NULL
Clin	NULL
Invest	NULL
83	NULL
,	NULL
752	NULL
.	NULL

Lacopzmskt	NULL
Z.	NULL
,	NULL
GoRsKI	NULL
A	NULL
.	NULL

&	NULL
Wasik	NULL
M.	NULL
(	NULL
1990	NULL
)	NULL
Immunosuppressive	NULL
action	NULL
of	NULL
low-dose	NULL
heparin	NULL
:	NULL
effect	NULL
on	NULL
skin	NULL
allograft	NULL
survival	NULL
.	NULL

Transplantation	NULL
50	NULL
,	NULL
714	NULL
.	NULL

Aziz	NULL
S.	NULL
,	NULL
Tapa	NULL
Y.	NULL
,	NULL
Gorpon	NULL
D.	NULL
,	NULL
McDonaLp	NULL
T.O	NULL
.	NULL

,	NULL
FarEED	NULL
J	NULL
.	NULL

&	NULL
Verrier	NULL
ED	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
A	NULL
reduction	NULL
in	NULL
accelerated	NULL
graft	NULL
coronary	NULL
disease	NULL
and	NULL
an	NULL
improvement	NULL
in	NULL
cardiac	NULL
allograft	NULL
survival	NULL
using	NULL
low	NULL
molecular	NULL
weight	NULL
heparin	NULL
in	NULL
combination	NULL
with	NULL
cyclosporine	NULL
.	NULL

J	NULL
Heart	NULL
Lung	NULL
Transplant	NULL
12	NULL
,	NULL
634	NULL
.	NULL

FULLER	NULL
L.	NULL
,	NULL
CARRENO	NULL
M.	NULL
,	NULL
EsqUENAZI	NULL
V.	NULL
et	NULL
al	NULL
(	NULL
1994	NULL
)	NULL
Characterization	NULL
of	NULL
anti-canine	NULL
cytokine	NULL
monoclonal	NULL
antibodies	NULL
specific	NULL
for	NULL
IFN-y	NULL
:	NULL
Effect	NULL
of	NULL
anti-IFN-y	NULL
on	NULL
renal	NULL
transplant	NULL
rejection	NULL
.	NULL

Tissue	NULL
Antigens	NULL
43	NULL
,	NULL
163	NULL
.	NULL

HAaLLORAN	NULL
P.F	NULL
.	NULL

,	NULL
Goes	NULL
N.	NULL
,	NULL
URmsoN	NULL
J.	NULL
et	NULL
a/	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
MHC	NULL
expression	NULL
in	NULL
organ	NULL
transplants	NULL
:	NULL
lessons	NULL
from	NULL
the	NULL
knock-out	NULL
mice	NULL
.	NULL

Transplant	NULL
Proc	NULL
29	NULL
,	NULL
1041	NULL
.	NULL

ApaMs	NULL
D.H.	NULL
&	NULL
Ltoyp	NULL
A.R	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
Chemokines	NULL
:	NULL
leucocyte	NULL
recruitment	NULL
and	NULL
activation	NULL
cytokines	NULL
.	NULL

Lancet	NULL
349	NULL
,	NULL
490	NULL
.	NULL

Brown	NULL
Z.	NULL
,	NULL
GERRITSEN	NULL
ME	NULL
.	NULL

,	NULL
Carey	NULL
W.W.	NULL
,	NULL
StRiETER	NULL
RM	NULL
.	NULL

,	NULL
KuNKEL	NULL
S.L	NULL
.	NULL

&	NULL
Wesrwick	NULL
J	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Chemokine	NULL
gene	NULL
expression	NULL
and	NULL
secretion	NULL
by	NULL
cytokine-activated	NULL
human	NULL
-	NULL
microvascular	NULL
endothelial	NULL
cells	NULL
.	NULL

Am	NULL
J	NULL
Pathol	NULL
145	NULL
,	NULL
913	NULL
.	NULL

TURNER	NULL
L.	NULL
,	NULL
Waro	NULL
S.G.	NULL
&	NULL
Westwick	NULL
J	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
RANTES-activated	NULL
human	NULL
T	NULL
lymphocytes	NULL
:	NULL
a	NULL
role	NULL
for	NULL
phosphoinositide	NULL
3-kinase	NULL
.	NULL

J	NULL
Immunol	NULL
155	NULL
,	NULL
2437	NULL
.	NULL

WiLsoN	NULL
J.L	NULL
.	NULL

,	NULL
Cunningham	NULL
A.C.	NULL
&	NULL
KirBy	NULL
J.A	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Alloantigen	NULL
presentation	NULL
by	NULL
B	NULL
cells	NULL
:	NULL
analysis	NULL
of	NULL
the	NULL
requirement	NULL
for	NULL
B	NULL
cell	NULL
activation	NULL
.	NULL

Immunology	NULL
86	NULL
,	NULL
325	NULL
.	NULL

DARNELL	NULL
J.E.J	NULL
.	NULL

,	NULL
Kerr	NULL
LM	NULL
.	NULL

&	NULL
Stark	NULL
G.R	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Jak-STAT	NULL
pathways	NULL
and	NULL
transcriptional	NULL
activation	NULL
in	NULL
response	NULL
to	NULL
IFNs	NULL
and	NULL
other	NULL
extracellular	NULL
signaling	NULL
proteins	NULL
.	NULL

Science	NULL
264	NULL
,	NULL
1415	NULL
.	NULL

ScHmipLer	NULL
U.	NULL
,	NULL
Wu	NULL
P.	NULL
,	NULL
RotHE	NULL
M.	NULL
,	NULL
Brasseur	NULL
M.	NULL
&	NULL
McKnight	NULL
S.L	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Components	NULL
of	NULL
a	NULL
Stat	NULL
recognition	NULL
code	NULL
:	NULL
evidence	NULL
for	NULL
two	NULL
layers	NULL
of	NULL
molecular	NULL
selectivity	NULL
.	NULL

Immunity	NULL
2	NULL
,	NULL
689	NULL
.	NULL

DoustLas	NULL
M.S	NULL
.	NULL

,	NULL
Rix	NULL
D.A	NULL
.	NULL

,	NULL
Dark	NULL
J.H	NULL
.	NULL

,	NULL
TarBot	NULL
D.	NULL
&	NULL
KirBy	NULL
J.A	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
Examination	NULL
of	NULL
the	NULL
mechanism	NULL
by	NULL
which	NULL
heparin	NULL
antagonizes	NULL
activation	NULL
of	NULL
a	NULL
model	NULL
endothelium	NULL
by	NULL
interferon-gamma	NULL
(	NULL
IFN-y	NULL
)	NULL
.	NULL

Clin	NULL
Exp	NULL
Immunol	NULL
107	NULL
,	NULL
578	NULL
.	NULL

25	NULL
26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

M.	NULL
S.	NULL
Douglas	NULL
et	NULL
al	NULL
.	NULL

.	NULL

Proost	NULL
P.	NULL
,	NULL
WuYTs	NULL
A	NULL
.	NULL

&	NULL
van	NULL
Damme	NULL
J	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Human	NULL
monocyte	NULL
chemotactic	NULL
proteins-2	NULL
and	NULL
-3	NULL
:	NULL
structural	NULL
and	NULL
functional	NULL
comparison	NULL
with	NULL
MCP-1	NULL
.	NULL

J	NULL
Leukocyte	NULL
Biol	NULL
59	NULL
,	NULL
67	NULL
.	NULL

Brown	NULL
Z.	NULL
,	NULL
Rosson	NULL
R.L	NULL
.	NULL

&	NULL
Westwick	NULL
J	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Regulation	NULL
and	NULL
expression	NULL
of	NULL
chemokines	NULL
:	NULL
potential	NULL
role	NULL
in	NULL
glomerulonephritis	NULL
.	NULL

J	NULL
Leukocyte	NULL
Biol	NULL
59	NULL
,	NULL
75	NULL
.	NULL

KuLraANE	NULL
A.	NULL
,	NULL
EKrE	NULL
H.P	NULL
.	NULL

,	NULL
PERLMANN	NULL
P.	NULL
,	NULL
RomBo	NULL
L.	NULL
,	NULL
WaHLGREN	NULL
M.	NULL
&	NULL
Warum	NULL
B	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Effect	NULL
of	NULL
different	NULL
fractions	NULL
of	NULL
heparin	NULL
on	NULL
Plasmodium	NULL
falciparum	NULL
merozoite	NULL
invasion	NULL
of	NULL
red	NULL
blood	NULL
cells	NULL
in	NULL
vitro	NULL
.	NULL

Am	NULL
J	NULL
Trop	NULL
Med	NULL
Hyg	NULL
46	NULL
,	NULL
589	NULL
.	NULL

Danzer	NULL
S	NULL
$	NULL
.G	NULL
.	NULL

,	NULL
Kircmner	NULL
H.	NULL
&	NULL
RmK	NULL
L.	NULL
(	NULL
1994	NULL
)	NULL
Cytokine	NULL
interactions	NULL
in	NULL
human	NULL
mixed	NULL
lymphocyte	NULL
culture	NULL
.	NULL

Transplantation	NULL
57	NULL
,	NULL
1638	NULL
.	NULL

Qm	NULL
S.	NULL
,	NULL
LaRosa	NULL
G.	NULL
,	NULL
CaMPBELL	NULL
J.J.	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Expression	NULL
of	NULL
monocyte	NULL
chemoattractant	NULL
protein-1	NULL
and	NULL
interleukin-8	NULL
receptors	NULL
on	NULL
subsets	NULL
of	NULL
T	NULL
cells	NULL
:	NULL
correlation	NULL
with	NULL
transendothelial	NULL
chemotactic	NULL
potential	NULL
.	NULL

Eur	NULL
J	NULL
Immunol	NULL
26	NULL
,	NULL
640	NULL
.	NULL

KaPELLER	NULL
R.	NULL
&	NULL
Cantey	NULL
LC	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Phosphatidylinositol	NULL
3-kinase	NULL
.	NULL

BioEssays	NULL
16	NULL
,	NULL
565	NULL
.	NULL

Lortat-Jacos	NULL
H.	NULL
&	NULL
Grimaup	NULL
J.A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Interferon-y	NULL
binds	NULL
to	NULL
heparan	NULL
sulphate	NULL
by	NULL
a	NULL
cluster	NULL
of	NULL
amino	NULL
acids	NULL
located	NULL
in	NULL
the	NULL
C-terminal	NULL
part	NULL
of	NULL
the	NULL
molecule	NULL
.	NULL

FEBS	NULL
Letters	NULL
280	NULL
,	NULL
152	NULL
.	NULL

Lortat-Jacos	NULL
H.	NULL
,	NULL
TurnNBuLL	NULL
J.E	NULL
.	NULL

&	NULL
Grimaup	NULL
J.A	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Molecular	NULL
organization	NULL
of	NULL
the	NULL
interferon-y-binding	NULL
domain	NULL
in	NULL
heparan	NULL
sulphate	NULL
.	NULL

Biochem	NULL
J	NULL
310	NULL
,	NULL
497	NULL
.	NULL

TANAKA	NULL
Y.	NULL
,	NULL
Apams	NULL
D.H.	NULL
,	NULL
HusscHer	NULL
S.	NULL
,	NULL
Hirano	NULL
H.	NULL
,	NULL
Stesenust	NULL
U	NULL
.	NULL

&	NULL
S.	NULL
(	NULL
1993	NULL
)	NULL
T-cell	NULL
adhesion	NULL
induced	NULL
by	NULL
proteoglycan-immobilized	NULL
cytokine	NULL
MIP-1f	NULL
.	NULL

Nature	NULL
361	NULL
,	NULL
79	NULL
.	NULL

Gat	NULL
D.	NULL
,	NULL
R.	NULL
,	NULL
MEkor1	NULL
Y.A	NULL
.	NULL

,	NULL
Viopavsky	NULL
I	NULL
.	NULL

&	NULL
Liner	NULL
O	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Regulation	NULL
of	NULL
adhesion	NULL
of	NULL
CD4*	NULL
T	NULL
Lymphocytes	NULL
to	NULL
intact	NULL
or	NULL
heparinase	NULL
treated	NULL
subendothelial	NULL
matrix	NULL
by	NULL
diffusible	NULL
or	NULL
anchored	NULL
RANTES	NULL
or	NULL
MIP-1	NULL
$	NULL
6	NULL
.	NULL

J	NULL
Immunol	NULL
153	NULL
,	NULL
4899	NULL
.	NULL

LUusTER	NULL
A.D.	NULL
,	NULL
GREENBERG	NULL
S.M	NULL
.	NULL

&	NULL
Leper	NULL
P.	NULL
(	NULL
1995	NULL
)	NULL
The	NULL
IP-10	NULL
chemokine	NULL
binds	NULL
to	NULL
a	NULL
specific	NULL
cell	NULL
surface	NULL
heparan	NULL
sulfate	NULL
site	NULL
shared	NULL
with	NULL
platelet	NULL
factor	NULL
4	NULL
and	NULL
inhibits	NULL
endothelial	NULL
cell	NULL
prolifer-ation	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
182	NULL
,	NULL
219	NULL
.	NULL

Wess	NULL
M.C	NULL
.	NULL

,	NULL
Enrenoruser	NULL
M.U	NULL
.	NULL

,	NULL
Crark-Lewis	NULL
L.	NULL
,	NULL
BagatoLmt	NULL
M	NULL
&	NULL
Rot	NULL
A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Binding	NULL
to	NULL
heparan	NULL
sulphate	NULL
or	NULL
heparin	NULL
enhances	NULL
neutrophil	NULL
responses	NULL
to	NULL
interleukin	NULL
8	NULL
.	NULL

Proc	NULL
Nat	NULL
!	NULL

Acad	NULL
Sci	NULL
USA	NULL
90	NULL
,	NULL
7158	NULL
.	NULL

Taus	NULL
D.D	NULL
.	NULL

,	NULL
Turcovski-CoRRALEs	NULL
S.M	NULL
.	NULL

,	NULL
Key	NULL
ML	NULL
.	NULL

,	NULL
Longo	NULL
D.L	NULL
.	NULL

&	NULL
MurpHvy	NULL
W.J	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Chemokines	NULL
and	NULL
T	NULL
lymphocyte	NULL
action	NULL
.	NULL

1	NULL
.	NULL

Beta	NULL
chemokines	NULL
costimulate	NULL
human	NULL
T	NULL
lymphocyte	NULL
activation	NULL
in	NULL
vitro	NULL
.	NULL

J	NULL
Immunol	NULL
156	NULL
,	NULL
2095	NULL
.	NULL

Taus	NULL
D.D	NULL
.	NULL

,	NULL
MurpHy	NULL
W.J	NULL
.	NULL

,	NULL
Asar	NULL
O.	NULL
et	NULL
al	NULL
(	NULL
1997	NULL
)	NULL
Induction	NULL
of	NULL
alloantigen-specific	NULL
Tcell	NULL
tolerance	NULL
through	NULL
the	NULL
treatment	NULL
of	NULL
human	NULL
T	NULL
lymphocytes	NULL
with	NULL
wortmannin	NULL
.	NULL

J	NULL
Immunol	NULL
!	NULL

158	NULL
,	NULL
2745	NULL
.	NULL

©1997	NULL
Blackwell	NULL
Science	NULL
Ltd	NULL
,	NULL
Immunology	NULL
,	NULL
92	NULL
,	NULL
512-518	NULL

